A body 300 having a cavity 310 for mounting a substrate 120 fabricated with probe sequences at known locations according to the methods disclosed in U.S. Pat. No. 5,143,854 and PCT WO 92/10092 or others, is provided. The cavity includes inlets 350 and 360 for introducing selected fluids into the cavity to contact the probes. Accordingly, a commercially feasible device for use in high throughput assay systems is provided.
DescriptionThis application is a continuation of U.S. application Ser. No. 10/229,759, filed on Aug. 28, 2002, which is a continuation of U.S. patent application Ser. No. 10/046,623, filed Jan. 14, 2002, now U.S. Pat. No. 6,551,817, which is a continuation of U.S. patent application Ser. No. 09/907,196, filed Jul. 17, 2001, now U.S. Pat. No. 6,399,365, which is a continuation of U.S. patent application Ser. No. 09/302,052, filed Apr. 29, 1999, now U.S. Pat. No. 6,287,850, which is a continuation of U.S. patent application Ser. No. 08/485,452, filed Jun. 7, 1995, now U.S. Pat. No. 5,945,334, which is continuation-in-part U.S. patent application Ser. No. 08/255,682, filed Jun. 8, 1994, now U.S. Pat. No. 6,140,044. Each of these applications is incorporated herein by reference in its entirety for all purposes.
The present inventions relate to the fabrication and placement of materials at known locations on a substrate. In particular, one embodiment of the invention provides a method and associated apparatus for packaging a substrate having diverse sequences at known locations on its surface.
Techniques for forming sequences on a substrate are known. For example, the sequences may be formed according to the pioneering techniques disclosed in U.S. Pat. No. 5,143,854 (Pirrung et al.), PCT WO 92/10092, or U.S. application Ser. No. 08/249,188, now U.S. Pat. No. 5,571,639, incorporated herein by reference for all purposes. The prepared substrates will have a wide range of applications. For example, the substrates may be used for understanding the structure-activity relationship between different materials or determining the sequence of an unknown material. The sequence of such unknown material may be determined by, for example, a process known as sequencing by hybridization. In one method of sequencing by hybridization, a sequences of diverse materials are formed at known locations on the surface of a substrate. A solution containing one or more targets to be sequenced is applied to the surface of the substrate. The targets will bind or hybridize with only complementary sequences on the substrate.
The locations at which hybridization occurs can be detected with appropriate detection systems by labeling the targets with a fluorescent dye, radioactive isotope, enzyme, or other marker. Exemplary systems are described in U.S. Pat. No. 5,143,854 (Pirrung et al.) and U.S. patent application Ser. No. 08/143,312, also incorporated herein by reference for all purposes. Information regarding target sequences can be extracted from the data obtained by such detection systems.
By combining various available technologies, such as photolithography and fabrication techniques, substantial progress has been made in the fabrication and placement of diverse materials on a substrate. For example, thousands of different sequences may be fabricated on a single substrate of about 1.28 cm2 in only a small fraction of the time required by conventional methods. Such improvements make these substrates practical for use in various applications, such as biomedical research, clinical diagnostics, and other industrial markets, as well as the emerging field of genomics, which focuses on determining the relationship between genetic sequences and human physiology.
As commercialization of such substrates becomes widespread, an economically feasible and high-throughput device and method for packaging the substrates are desired.
Methods and devices for packaging a substrate having an array of probes fabricated on its surface are disclosed. In some embodiments, a body containing a cavity is provided. A substrate having an array of probes is attached to the cavity using, for example, an adhesive. The body includes inlets that allow fluids into and through the cavity. A seal is provided for each inlet to retain the fluid within the cavity. An opening is formed below the cavity to receive a temperature controller for controlling the temperature in the cavity. By forming a sealed thermostatically controlled chamber in which fluids can easily be introduced, a practical medium for sequencing by hybridization is provided.
In other embodiments, the body is formed by acoustically welding two pieces together. The concept of assembling the body from two pieces is advantageous. For example, the various features of the package (i.e., the channels, sealing means, and orientation means) are formed without requiring complex machining or designing. Thus, the packages are produced at a relatively low cost.
In connection with one aspect of the invention, a method for making the chip package is disclosed. In particular, the method comprises the steps of first forming a plurality of probe arrays on a substrate and separating the substrate into a plurality of chips. Typically, each chip contains at least one probe array. A chip is then mated to a package having a reaction chamber with fluid inlets. When mated, the probe array is in fluid communication with the reaction chamber.
In a specific embodiment, the present invention provides an apparatus for packaging a substrate. The present apparatus includes a substrate having a first surface and a second surface. The first surface includes a probe array and the second surface is an outer periphery of the first surface. The present apparatus also includes a body having a mounting surface, an upper surface, and a cavity bounded by the mounting surface and the upper surface. The second surface is attached to the cavity and the first surface is within the cavity. A cover attached to the mounting surface for defining an upper boundary to the cavity is also included. The cavity includes a diffuser and a concentrator. The diffuser and the concentrator permit laminar fluid flow through the cavity.
A further understanding of the nature and advantages of the inventions herein may be realized by reference to the remaining portions of the specification and the attached drawings.
FIG. 1 a illustrates a wafer fabricated with a plurality of probe arrays.
FIG. 1 b illustrates a chip.
FIG. 2 a illustrates a scribe and break device.
FIG. 2 b illustrates the wafer mounted on a pick and place frame.
FIGS. 2 c-2 d illustrate the wafer, as displayed by the scribe and break device during alignment.
FIG. 3 illustrates a chip packaging device.
FIG. 4 illustrates the chip packaging device assembled from two components.
FIGS. 5 a-5 b illustrate the top and bottom view of a top casing of the chip packaging device.
FIG. 5 c illustrates a different cavity orientation.
FIG. 6 illustrates a cross sectional view of the packaging device.
FIG. 7 illustrates the bottom view of a bottom casing of the chip packaging device.
FIGS. 8 a-8 b illustrate an acoustic welding system.
FIGS. 9 a-9 c illustrate the acoustic welding process used in assembling the chip packaging device.
FIG. 10 illustrates an adhesive dispensing system used in attaching the chip to the chip packaging device.
FIGS. 11-13 illustrate in greater detail the adhesive dispensing system of FIG. 10 .
FIGS. 14 a-14 d illustrate the procedure for aligning the system of FIG. 10 .
FIGS. 15 a-15 e illustrate images obtained during the alignment process of FIGS. 14 a-14 d.
FIGS. 16 a-16 b illustrate an alternative embodiment of a packaging device.
FIGS. 17 a-17 b illustrate another embodiment of a packaging device.
FIG. 18 illustrates an alternative embodiment for attaching the chip to the packaging device.
FIG. 19 illustrates another embodiment for attaching the chip to the packaging device.
FIGS. 20 a-20 b illustrate yet another embodiment for attaching the chip to the packaging device.
FIG. 21 illustrates an alternative embodiment for attaching the chip to the packaging device.
FIG. 22 illustrates another embodiment for attaching the chip to the packaging device.
FIG. 23 illustrates an alternative embodiment for sealing the cavity on the packaging device.
FIG. 24 illustrates another alternative embodiment for sealing the cavity on the packaging device.
FIG. 25 illustrates yet another embodiment for sealing the cavity on the packaging device.
FIGS. 26 a-26 b illustrate an alternative embodiment for sealing the cavity on the packaging device.
FIGS. 27 a-27 b illustrate an alternative embodiment for mounting the chip.
FIG. 28 illustrates an agitation system.
FIG. 29 illustrates an alternative embodiment of the agitation system.
FIG. 30 illustrates another embodiment of the agitation system.
FIG. 31 illustrates an alternative embodiment of a chip packaging device.
FIG. 32 illustrates side-views of the chip packaging device of FIG. 31 .
FIGS. 33-35 illustrate in greater detail the chip packaging device of FIG. 31 .
FIG. 36 illustrates a further alternative embodiment of a chip packaging device.
The following terms are intended to have the following general meanings as they are used herein:
The present invention provides economical and efficient packaging devices for a substrate having an array of probes fabricated thereon. The probe arrays may be fabricated according to the pioneering techniques disclosed in U.S. Pat. No. 5,143,854 (Pirrung et al.), PCT WO 92/10092, or U.S. application Ser. No. 08/249,188 filed May 24, 1994, already incorporated herein by reference for all purposes. According to one aspect of the techniques described therein, a plurality of probe arrays are immobilized at known locations on a large substrate or wafer.
FIG. 1 a illustrates a wafer 100 on which numerous probe arrays 110 are fabricated. The wafer 100 may be composed of a wide range of material, either biological, nonbiological, organic, inorganic, or a combination of any of these, existing as particles, strands, precipitates, gels, sheets, tubing, spheres, containers, capillaries, pads, slices, films, plates, slides, etc. The wafer may have any convenient shape, such as a disc, square, sphere, circle, etc. The wafer is preferably flat but may take on a variety of alternative surface configurations. For example, the wafer may contain raised or depressed regions on which a sample is located. The wafer and its surface preferably form a rigid support on which the sample can be formed. The wafer and its surface are also chosen to provide appropriate light-absorbing characteristics. For instance, the wafer may be a polymerized Langmuir Blodgett film, functionalized glass, Si, Ge, GaAs, GaP, SiO2, SiN4, modified silicon, or any one of a wide variety of gels or polymers such as (poly)tetrafluoroethylene, (poly)vinylidenedifluoride, polystyrene, polycarbonate, or combinations thereof. Other materials with which the wafer can be composed of will be readily apparent to those skilled in the art upon review of this disclosure. In a preferred embodiment, the wafer is flat glass or single-crystal silicon.
Surfaces on the solid wafer will usually, though not always, be composed of the same material as the wafer. Thus, the surface may be composed of any of a wide variety of materials, for example, polymers, plastics, resins, polysaccharides, silica or silica-based materials, carbon, metals, inorganic glasses, membranes, or any of the above-listed wafer materials.
Wafer 100 includes a plurality of marks 145 that are located in streets 150 (area adjacent to the probe arrays). Such marks may be used for aligning the masks during the probe fabrication process. In effect, the marks identify the location at which each array 110 is to be fabricated. The probe arrays may be formed in any geometric shape. In some embodiments, the shape of the array may be squared to minimize wasted wafer area. After the probe arrays have been fabricated, the wafer is separated into smaller units known as chips. The wafer, for example, may be about 5Ã5 inches on which 16 probe arrays, each occupying an area of about 12.8 cm2, are fabricated.
FIG. 1 b illustrates a chip that has been separated from the wafer. As illustrated, chip 120 contains a probe array 110 and a plurality of alignment marks 145. The marks serve multiple functions, such as: 1) aligning the masks for fabricating the probe arrays, 2) aligning the scriber for separating the wafer into chips, and 3) aligning the chip to the package during the attachment process. In some embodiments, such chips may be of the type known as Very Large Scale Immobilized Polymer Synthesis (VLSIPSâ¢) chips.
According to a specific embodiment, the chip contains an array of genetic probes, such as an array of diverse RNA or DNA probes. In some embodiments, the probe array will be designed to detect or study a genetic tendency, characteristic, or disease. For example, the probe array may be designed to detect or identify genetic diseases such as cystic fibrosis or certain cancers (such as P53 gene relevant to some cancers), as disclosed in U.S. patent application Ser. No. 08/143,312, already incorporated by reference.
According to one embodiment, the wafer is separated into a plurality of chips using a technique known as scribe and break. FIG. 2 a illustrates a fully programmable computer controlled scribe and break device, which in some embodiments is a DX-III Scriber breaker manufactured by Dynatex Infemationalâ¢. As shown, the device 200 includes a base 205 with a rotation stage 220 on which a wafer is mounted. The rotation stage includes a vacuum chuck for fixing the wafer thereon. A stepper motor, which is controlled by the system, rotates stage 220. Located above the stage is a bead unit 230 that includes a camera 232 and cutter 231. Head unit 230 is mounted on a dual-axis frame. The camera generates an image of the wafer on video display 210. The video display 210 includes a cross hair alignment mark 215. The camera, which includes a zoom lens and a fiber optic light, allows a user to inspect the wafer on the video display 210. A control panel 240 is located on the base for operating device 200.
In operation, a user places a wafer 100 on a frame 210 as illustrated in FIG. 2 b. The surface of frame 210 is composed of a flexible and sticky material. The tackiness of the frame prevents the chips from being dispersed and damaged during the breaking process. Frame 210 may be a pick and place frame or a hoop that is commonly associated with fabrication of semiconductors. Referring back to FIG. 2 a, a user places the frame with the wafer on the rotation stage 220. In some embodiments, the frame is held on the rotation stage by vacuum pressure. The user then aligns the wafer by examining the image displayed on the video display 210.
According to one embodiment, wafer alignment is achieved in two steps. First, using the control panel 240, the user rotates stage 220. The stage is rotated until streets 150 are aligned with the cross hair 215 on the display, as illustrated in FIG. 2 c. Next, the user moves the cutter until it is aligned at the center of one of the streets. This step is performed by aligning horizontal line 216 of the cross hair between alignment marks 145, as shown in FIG. 2 d.
Once the cutter is aligned, the user instructs the device to scribe the wafer. In some embodiments, various options are available to the user, such as scribe angle, scribe pressure, and scribe depth. These parameters will vary depending on the composition and/or thickness of the wafer. Preferably, the parameters are set to scribe and break the wafer without causing any damage thereto or penetrating through the frame. The device repeatedly scribes the wafer until all the streets in one axis have been scribed, which in one embodiment is repeated 5 times (a 4Ã4 matrix of probe arrays). The user then rotates the stage 90° to scribe the perpendicular streets.
Once the wafer has been scribed, the user instructs the device to break or separate the wafer into chips. Referring back to FIG. 2 a, the device 200 breaks the wafer by striking it beneath the scribe with an impulse bar located under the rotation table 220. The shock from the impulse bar fractures the wafer along the scribe. Since most of the force is dissipated along the scribe, device 200 is able to produce high breaking forces without exerting significant forces on the wafer. Thus, the chips are separated without causing any damage to the wafer. Once separated, the chips are then packaged. Of course, other more conventional techniques, such as the sawing technique disclosed in U.S. Pat. No. 4,016,855, incorporated herein by reference for all purposes, may be employed.
III. Details of One Embodiment of the Invention
a. Chip Package
FIG. 3 illustrates a device for packaging the chips. Package 300 contains a cavity 310 on which a chip is mounted. The package includes inlets 350 and 360 which communicate with cavity 310. Fluids are circulated through the cavity via inlets 350 and 360. A septum, plug, or other seal may be employed to seal the fluids in the cavity. Alignment holes 330 and 335 may be provided for alignment purposes. In some embodiments, the package may include a non-flush edge 320. In some detection systems, the packages may be inserted into a holder similar to an audio cassette tape. The asymmetrical design of the package will assure correct package orientation when inserted into the holder.
FIG. 4 illustrates one embodiment of the package. As shown in FIG. 4 , the chip package is manufactured by mating two substantially complementary casings 410 and 420 to form finished assembly 300. Preferably, casings 410 and 420 are made from injection molded plastic. Injection molding enables the casings to be formed inexpensively. Also, assembling the package from two parts simplifies the construction of various features, such as the internal channels for introducing fluids into the cavity. As a result, the packages may be manufactured at a relatively low cost.
FIGS. 5 a-5 b show the top casing 410 in greater detail. FIG. 5 a shows a top view and FIG. 5 b shows a bottom view. Referring to FIG. 5 a, top casing 410 includes an external planar surface 501 having a cavity 310 therein. In some embodiments, the surface area of casing 410 sufficiently accommodates the cavity. Preferably, the top casing is of sufficient size to accommodate identification labels or bar codes in addition to the cavity. In a specific embodiment, the top casing is about 1.5â³ wide, 2â³ long, and 0.2â³ high.
Cavity 310 is usually, though not always, located substantially at the center of surface 501. The cavity may have any conceivable size, shape, or orientation. Preferably, the cavity is slightly smaller than the surface area of the chip to be placed thereon and has a volume sufficient to perform hybridization. In one embodiment, the cavity may be about 0.58â³ wide, 0.58â³ long, and 0.2â³ deep.
Cavity 310 may include inlets 350 and 360. Selected fluids are introduced into and out of the cavity via the inlets. In some embodiments, the inlets are located at opposite ends of the cavity. This configuration improves fluid circulation and regulation of bubble formation in the cavity. The bubbles agitate the fluid, increasing the hybridization rate between the targets and complementary probe sequences. In one embodiment, the inlets are located at the top and bottom end of the cavity when the package is oriented vertically such as at the opposite corners of the cavity. Locating the inlet at the highest and lowest positions in the cavity facilitates the removal of bubbles from the cavity.
FIG. 5 c illustrates an alternative embodiment in which cavity 310 is oriented such that the edges of the cavity 310 and the casing 410 are non-parallel. This configuration allows inlets 350 and 360 to be situated at the absolute highest and lowest locations in the cavity when the package is vertically oriented. As a result, bubbles or fluid droplets are prevented from being potentially trapped in the cavity.
Referring back to FIG. 5 a, a depression 550 surrounds the cavity. In some embodiments, a ridge 560 may be provided at the edge of the depression so as to form a trough. The ridge serves to support the chip above the cavity. To attach the chip to the package, an adhesive may be deposited in the trough. This configuration promotes efficient use of chip surface area, thus increasing the number of chips yielded from a wafer.
Top casing 410 includes alignment holes 330 and 335. In some embodiments, holes 330 and 335 are different in size to ensure correct orientation of the package when mounted on an alignment table. Alternatively, the holes may have different shapes to achieve this objective. Optionally, the holes taper radially inward from surface 501 toward 502 to reduce the friction against alignment pins while still maintaining adequate contact to prevent slippage.
Referring to FIG. 5 b, channels 551 and 561 are optionally formed on internal surface 502. Channels 551 and 561 communicate with inlets 350 and 360 respectively. A depression 590 is formed below cavity. According to some embodiments, the shape of depression 590 is symmetrical to the cavity with exception to corners 595 and 596, which accommodate the inlets. The depth of depression 590 may be, for example, about 0.7â³. As a result, the bottom wall of the cavity is about 0.05â³ thick. Depression 590 may receive a temperature controller to monitor and maintain the cavity at the desired temperature. By separating the temperature controller and cavity with a minimum amount of material, the temperature within the cavity may be controlled more efficiently and accurately. Alternatively, channels may be formed on surface 502 for circulating air or water to control the temperature within the cavity.
In some embodiments, certain portions 595 of internal surface 502 may be eliminated or cored without interfering with the structural integrity of the package when assembled. Coring the casing reduces the wall thickness, causing less heat to be retained during the injection molding process; potential shrinkage or warpage of the casing is significantly reduced. Also, coring decreases the time required to cool the casing during the manufacturing process. Thus, manufacturing efficiency is improved.
In one embodiment, the top casing and bottom casing are mated together using a technique known as acoustic or ultrasonic welding. Accordingly, âenergy directorsâ 510 are provided. Energy directors are raised ridges or points, preferably v-shaped, that are used in an acoustic welding process. The energy directors are strategically located, for example, to seal the channels without interfering with other features of the package and to provide an adequate bond between the two casings. Alternatively, the casings may be mated together by screws, glue, clips, or other mating techniques.
FIG. 6 shows a cross sectional view of the cavity 310 with chip 120 mounted thereon in detail. As shown, a depression 550 is formed around cavity 310. The depression includes a ridge 560 which supports chip 120. The ridge and the depression create a trough around cavity 310. In some embodiments, the trough is sufficiently large to receive an adhesive 630 for attaching the chip to the package. In one embodiment, the trough is about 0.08â³ wide and 0.06â³ deep. When mounted, the edge of the chip protrudes slightly beyond ridge 550, but without contacting side 625 of the depression. This configuration permits the adhesive to be dispensed onto the trough and provides adequate surface area for the adhesive to attach chip 120 to the package.
According to some embodiments, the back surface 130 of chip 120 is at least flush or below the plane formed by surface 501 of casing 410. As a result, chip 120 is shielded by surface 501 from potential damage. This configuration also allows the packages to be easily stored with minimal storage area since the surfaces are substantially flat.
Optionally, the bottom of the cavity includes a light absorptive material, such as a glass filter or carbon dye, to prevent impinging light from being scattered or reflected during imaging by detection systems. This feature improves the signal-to-noise ratio of such systems by significantly reducing the potential imaging of undesired reflected light.
FIG. 7 shows the internal surface of bottom casing 420 in greater detail. As shown, the bottom casing 420 is substantially planar and contains an opening 760 therein. Preferably, the casing 420 is slightly wider or slightly longer than the top casing. In one embodiment, casing 420 is about 1.6â³ wide, 2.0â³ long, and 0.1â³ deep, which creates a non-flush edge on the finish assembly. As previously mentioned, this design ensures that the package is correctly oriented when mounted onto the detection systems.
In some embodiments, opening 760 is spatially located at about the depression below the cavity. The opening also has substantially the same geometric configuration as the depression to allow the temperature controller to contact as much of the bottom of the cavity as possible.
Internal surface 701 of casing 420 includes depressions 730 and 740. A port 731 is located in depression 730 and a port 741 is located in depression 740. Ports 731 and 741 communicate with channels on the top casing (350 and 360 in FIG. 5 b) when the package is assembled. A seal 790, which may be a septum composed of rubber, teflon/rubber laminate, or other sealing material is provided for each depression. The septum may be of the type commonly used to seal and reseal vessels when a needle is inserted into the septum for addition/removal of fluids. The septums, when seated in the depressions, extend slightly above surface, which in some embodiments is about 0.01â³.
This design causes casings 410 and 420 to exert pressure on the septum, forming a seal between the ports and the channels. The seal is maintained even after fluid is injected into the cavity since the pressure immediately forces the septum to reseal itself after the needle or other fluid injecting means is removed from the port. Thus, an efficient and economical seal for retaining fluid in the cavity is provided.
Also, casing 420 includes the complementary half alignment holes 330 and 335, each tapering radially inward from the external surface. Further, certain areas 765 on internal surface 701 may be cored, as similar to the internal surface of the top casing.
FIG. 31 is a simplified illustration of an alternative embodiment of a chip packaging device 3100 according to the present invention. The chip packaging device includes a plurality of casings 3200, 3300, and 3400. The casings may be defined as a top casing 3200, a middle casing 3300, and a bottom casing 3400. The casings are made of known plastic materials such as ABS plastic, polyvinylchloride, polyethylene, products sold under the trademarks TEFLON⢠and KALREZ⢠and the like, among others. Preferably, the casings can be made by way of injection molding and the like. Assembling the chip packaging device from three casings simplifies construction for the fabrication of internal channels and the like, and can also be made at a relatively low cost.
Support structures (or alignment holes) exist at selected locations of the chip packing device. The support structures can be used to mount or position the chip packaging device to an apparatus, e.g., scanner or the like. In an embodiment, the top casing 3200 includes support structures 3201 and 3203 on each side of a center opening 3209. The middle casing 3300 includes similar support structures 3313 and 3315 which are complementary to the support structures 3201 and 3203, respectively, in the top casing. The bottom casing also includes similar support structures 3403 and 3401, respectively, which are complementary to the support structures in the top casing and the middle casing. As shown, each of the support structures on each side of the center opening align with each other. Each support structure is, for example, an aperture through the casing. The aperture includes an outer periphery defined by a geometrical shape which may be round, rectangular, trapezoidal, hexagonal, or the like.
The present chip packaging device assembles with use of complementary alignment pins and bores on the casings. By way of alignment pins (not shown), the top casing aligns with and inserts into alignment bores 3301, 3303 in the middle casing 3300. Alternatively, the middle casing can have alignment pins or the like and the top casing has the alignment bores or the like. The bottom casing includes alignment pins 3407 and 3409 which align to and insert into alignment bores (not shown) in bottom portions of the middle casing. The use of alignment bores and pins provide for ease in assembly of the chip carrier. Upon assembly, the alignment bores and pins on the casings prevent the casings from moving laterally relative to each other.
A center opening 3209 in the top casing overlies a center portion 3317 of the middle casing 3300. The center portion 3317 of the middle casing includes an inner annular region (or cavity edges) with a bottom portion which is preferably a flat bottom portion. The flat bottom portion of the middle casing and portions of the bottom casing including edges define a cavity 3405. A chip is placed overlying an underlying portion of the cavity 3407.
Optionally, a temperature control mechanism such as a heater, a cooler, or a combination thereof is disposed into the center opening against the bottom portion of the middle casing. The temperature control mechanism can be any suitable thermally controlled element such as a resistive element, a temperature controlled block or mass, thermoelectric modules, or the like. The temperature control mechanism transfers heat via conduction to the bottom center portion, which transfers heat to, for example, fluid in the cavity or the chip. Alternatively, the temperature control mechanism sinks heat away from, for example, fluid in the cavity or the chip through the bottom center portion. The temperature control mechanism maintains a selected temperature in the cavity. The temperature control mechanism also includes a temperature detection device such as a thermocouple which provides signals corresponding to temperature readings. A controller receives the signals corresponding to the temperature readings, and adjusts power output to the temperature control mechanism to maintain the selected temperature.
The top casing 3200 also includes channels 3205 and 3207 for fluid transfer. The channels 3205 and 3207 communicate with annular regions 3309 and 3311, respectively, on the middle casing 3300 for fluid transfer. A septum, a plug, an o-ring, a gasket, or the like via annular regions 3309 and 3311 seals fluids within the top casing channels 3205 and 3207 and the middle casing. The bottom casing includes channels 3411 and 3413 in communication with channels 3307 and 3305, respectively. A septum, a plug, an o-ring, a gasket, or the like seals the fluids within the bottom casing channels 3411 and 3413 and the middle casing channels 3305 and 3307.
The chip packaging device provides an even distribution of fluid (or fluid flow) through the cavity over a top surface (or inner or active surface) of the chip. For example, a selected fluid enters channel 3207, flows through channel 3307, changes direction and flows through channel 3411, and evenly distributes into the cavity 3405 over the top surface of the chip. As previously noted, the cavity is defined by the flat bottom portion and cavity edges. A selected fluid exits the cavity by way of channel 3413, channel 3305, and channel 3205. The fluid flow over the top surface of the chip is preferably laminar, but may also be turbulent, a combination thereof or the like. By way of the present chip packaging device, a substantial portion of turbulent flow remains at an upper portion of the channel 3411, and does not enter the cavity.
Preferably, a selected fluid enters the cavity by way of channel 3205, channel 3305, and channel 3413. The selected fluid exits the cavity through channel 3411, channel 3307, and channel 3207. In a preferred embodiment, the fluid flows against the direction of gravity through the cavity. Of course, other fluid flow routes may also be employed depending upon the particular application.
FIG. 32 illustrates an assembled chip packaging device 3100 according to the present invention. As shown are a top- view 3200, a side- view 3500, a bottom- view 3400, and a front- view 3600 of the assembled chip packaging device 3100. The assembled chip packaging device 3100 includes the bottom casing 3400, the middle casing 3300, and the top casing 3200.
The top- view 3200 of the top casing includes alignment structures 3205, 3215 surrounding opening 3209. The opening 3209 includes a bevelled annular region 3211 surrounding the periphery of the channel 3209. The alignment bores 3203 and 3201 also include bevelled annular regions 3213 and 3215, respectively. A bevelled annular region 3217, 3221 also surrounds each fluid channel 3205, 3207 to assist with fluid flow therethrough.
The bottom- view 3400 of the bottom casing includes alignment structures 3401, 3403 surrounding the cavity 3405. The cavity includes a flat bottom peripheral portion 3415, a bevelled portion 3417 extending from the flat bottom peripheral portion, and a flat upper portion 3419 surrounding the bevelled portion. The chip includes an outer periphery which rests against the flat bottom peripheral portion 3415. The bevelled portion aligns the chip onto the flat bottom peripheral portion 3415. Similar to the previous embodiments, the top casing extends outside 3421 the middle and bottom casings.
The cavity 3405 is preferably located at a center of the bottom casing, but may also be at other locations. The cavity may be round, square, rectangular, or any other shape, and orientation. The cavity is preferably smaller than the surface area of the chip to be placed thereon, and has a volume sufficient to perform hybridization and the like. In one embodiment, the cavity includes dimensions such as a length of about 0.6 inch, a width of about 0.6 inch and a depth of about 0.07 inch.
In a preferred embodiment, the bottom casing with selected cavity dimensions may be removed from the middle and top casings, and replaced with another bottom casing with different cavity dimensions. This allows a user to attach a chip having a different size or shape by changing the bottom casing, thereby providing ease in using different chip sizes, shapes, and the like. Of course, the size, shape, and orientation of the cavity will depend upon the particular application.
FIGS. 33-35 illustrate in greater detail the chip packaging device of FIG. 31 . FIG. 33 illustrates simplified top- view 3260 and bottom- view 3250 diagrams of the top casing 3200. As shown, the reference numerals refer to the same elements as the top casing of FIG. 31 . FIG. 34 illustrates a simplified top- view 3350 and bottom- view 3360 diagrams of the middle casing 3300. As shown the reference numerals refer to the same elements as the middle casing of FIG. 31 . In addition, the bottom-view of the casing includes a substantially smooth and planar bottom surface 3361. A portion of the bottom surface defines an upper portion of the cavity. But the bottom surface can also be textured, ridged, or the like to create turbulence or a selected fluid flow through the cavity. The bottom surface is preferably a hydrophobic surface which enhances laminar flow through the cavity. Of course, the type of bottom surface depends upon the particular application.
FIG. 35 illustrates simplified top- view 3460 and bottom- view 3450 diagrams of the bottom casing 3400. As shown, the reference numerals refer to the same elements as the bottom casing of FIG. 31 . In an embodiment, fluid from channel 3305 changes direction at an upper portion 3431 of the channel and flows to a lower portion 3433 of the channel. Fluid evenly distributes from the lower portion 3433 via a fluid distribution point 3435. The distributed fluid evenly passes over a slanted edge (or bevelled edge) 3437 which drops fluid evenly to a top surface of the chip in the cavity. By way of slanted edge 3427 which slopes up to a fluid concentration point 3425, fluid leaves the cavity and enters the channel 3411. In particular, fluid leaves the cavity and enters a lower portion 3423 of the channel, flows through the channel, and changes directions at an upper portion 3421 of the channel. Each channel includes a length L and a width W. The distribution point and the concentration point are positioned at a distance away from the cavity to substantially prevent turbulence from forming in the cavity, and in particular over the top surface of the chip. The channels are each angled at an angle Î ranging from about 2 degrees to about 90 degrees, but is preferably about 5 degrees to about 45 degrees. The angle enhances an even distribution of laminar flow into the cavity. Of course, the exact angle, channel shape, and dimensions depend upon the particular application.
FIG. 36 illustrates a simplified cross-sectional view of an alternative embodiment 3600 of the chip packaging device. The chip packaging device includes the three casings 3200, 3300, and 3400 of the previous embodiment, and also includes hollow pins, needles, or the like 3601 and 3603. Each of the pins transfers a selected fluid to and from the cavity 3405. Preferably, each pin 3601 includes an external opening 3609, a tubular region 3611, an inner opening 3607, a pointed tip 3605, and other elements. The pin is made from a suitable material such as a glass, a stainless steel or any other high quality material to transfer fluids to and from the cavity 3405.
In a preferred embodiment, each pin is inserted into its channel region 3205 or 3207. A point on the pin tip pierces through, for example, a septum at an annular region 3309 or 3311. A selected fluid travels through pin 3603 (through channel 3205 and at least a portion of 3305), enters the upper region of channel 3413, and into the cavity 3405. The selected fluid travels from the cavity, through pin 3601, and to the external apparatus. Alternatively, the selected fluid enters the cavity via pin 3601 and exits the cavity via pin 3603. The selected fluid may also enter the cavity via pin and exit the cavity through the channels without use of a pin. The selected fluid may further enter the cavity through the channels without use of a pin and exit through a pin. Of course, the particular pin used and fluid flow will depend upon the application.
It should be noted that the even distribution of fluid flow through the cavity prevents âhot spotsâ from occurring in the cavity. For example, the even distribution of fluid through the cavity by way of the previous embodiment substantially prevents fluid from becoming substantially turbulent at certain locations. This prevents âhot spotsâ caused by such turbulent fluid. The hot spots are often caused by higher chemical activity or exothermic reactions and the like by way of turbulence in such certain locations.
b. Assembly of Chip Package
According to one embodiment, the top and bottom casing are attached by a technique known as ultrasonic or acoustic welding. FIG. 8 a is a schematic diagram of acoustic welding system used for assembling the package. In some embodiments, the welding system 800 is a HS Dialog ultrasonic welder manufactured by Herrmann Ultrasonics Inc. System 800 includes a platform 850 mounted on base 810. Platform 850 accommodates the top and bottom casings during the assembling process.
An acoustic horn 860 is mounted on a frame above platform 850. The horn translates vertically (toward and away from platform 850) on the frame by air pressure. The horn is connected to a frequency generator 870, which in some embodiments is a 20 KHz generator manufactured by Herrmann Ultrasonics Inc. System 800 is controlled by a controller 880, which, for example, may be a Dialog 2012 manufactured by Herrrnann Ultrasonics Inc. Controller 880 may be configured to accept commands from a digital computer system 890. Computer 890 may be any appropriately programmed digital computer of the type that is well known to those skilled in the art such as a Gateway 486DX operating at 33 MHz.
FIG. 8 b illustrates platform 850 in greater detail. The platform 850 is substantially planar and includes alignment pins 851 and 852. Alignment pins 851 and 852 are used to align both the top and bottom casings during the welding process. In some embodiments, a pad 890, which may be composed of silicone rubber or other energy absorbing material, is located on platform 850 to prevent damage to the package during assembly.
FIG. 9 a illustrates the acoustic welding system in operation. As shown, bottom casing 420, having a septum 790 seated in each depression, is mounted onto platform table 850 and held in place by alignment pins. Top casing 410 is then aligned above the bottom casing with alignment pins. The system then commences the welding process by lowering horn 860 until it contacts the top surface of casing 410.
FIG. 9 b illustrates the casing and horn in detail. As shown, the horn 860 presses against top casing 410, thereby forcing energy directors 510 to interface with bottom casing 420. The system then activates the frequency generator, causing the welding horn to vibrate.
FIG. 9 c illustrates in detail the energy directors during the welding process. As shown in step 9001, welding horn 860 forces energy directors 510 against bottom casing 420. At step 9002, the system vibrates the welding horn, which in some embodiments is at 20 KHz. The energy generated by the horn melts the energy directors. Simultaneously, the horn translates downward against the package. At step 9003, the pressure exerted by the horn causes the energy directors to fuse with the bottom casing. At step 9004, the welding process is completed when the horn reaches its weld depth, for example, of about 0.01â³. Of course, the various welding parameters may be varied, according to the composition of the materials used, to achieve optimum results.
c. Chip Attachment
According to some embodiments, an ultraviolet cured adhesive attaches the chip to the package. FIG. 10 schematically illustrates an adhesive dispensing system used in attaching the chip. The dispensing system 1000 includes an attachment table 1040 to accommodate the package during the attachment process. A chip alignment table 1050 for aligning the chip is located adjacent to attachment table 1040. A head unit 1030 for dispensing the adhesive is located above tables 1040 and 1050. The head unit 1030 also includes a camera that generates an output to video display 1070. Video display 1070, in some embodiments, includes a cross hair alignment mark 1071. The head unit is mounted on a dual-axis (x-y) frame for positioning during alignment and attachment of the chip. The operation of the dispensing system is controlled by a computer 1060, which in some embodiments may be Gateway 486DX operating at 33 MHz.
FIG. 11 illustrates the attachment table in greater detail. The attachment table 1040 has a substantially flat platform 1110 supported by a plurality of legs 1105. Alignment pins 1115 and 1116, which secure the package during the attachment process, are located on the surface of platform 1110.
Optionally, a needle 1120 is provided. Needle 1120 includes a channel 1121 and is connected to a vacuum pump. In operation, the needle is inserted into one of the ports of the package in order to generate a vacuum in the cavity. The vacuum pressure secures the chip to the package during the attachment process.
FIG. 12 a shows table 1050 in greater detail. Table 1050 includes a substantially flat platform 1210 having a depression 1240 for holding a chip. In some embodiments, a port 1241 is provided in depression 1240. Port 1241 is connected to a vacuum pump which creates a vacuum in the depression for immobilizing the chip therein. Platform 1210 is mounted on a combination linear rotary stage 1246, which in some embodiments may be a model 26LR manufactured by DARDAL, and a single axis translation stage 1245, which may be a model CR2226HSE2 manufactured by DARDAL.
FIG. 12 b illustrates depression 1240 in greater detail. As shown, a ledge 1241 surrounds the depression 1240. Ledge 1241 supports the chip when it is placed above depression 1240. Since the chips are placed over the depression with the probes facing the table, this design protects the probes from being potentially damaged during alignment.
FIG. 13 illustrates the head unit 1030 in greater detail. As shown, the head unit 1030 includes a camera assembly 1320 that generates an output to a video display. A light 1360 is provided to enable the camera to focus and image an object of interest. The head unit also includes an ultraviolet light 1350 for curing the adhesive, a vacuum pickup 1330 for moving chip during the attachment process, and an adhesive dispenser 1340.
In operation, a chip package is placed onto table 1040. As previously described, the alignment pins on the table immobilize the package. The user begins the chip attachment process by calibrating the head unit. This may be done by moving the camera above the package and aligning it with a mark on the package, as shown in FIG. 14 a. For convenience, one of the alignment pins may be used as an alignment mark. FIG. 14 b illustrates a typical image 1440 generated by the camera during this step. As shown, the head unit is not aligned with pin 1480. To align the bead unit, the user translates it in both the x and y direction until pin 1480 is located at the intersection 1477 of the cross hair on the video display, as illustrated in FIG. 14 c.
Next, the chip is inserted into the depression on the chip alignment table. FIG. 14 c is a flow chart indicating the steps for aligning the chip. At step 1410, the system positions the camera (head unit) above one of the chip's alignment marks. The camera images the alignment mark on the video display. At this point, the mark is normally misaligned (i.e., the mark is not located at the intersection of the cross hair alignment mark). At step 1420, the user adjusts the chip alignment table in both the x and y direction until the mark is substantially located at the intersection of the cross hair. Since no rotational adjustments were made, the mark may be misaligned angularly.
At step 1430, the user instructs the system to move the camera above a second alignment mark, which usually is at an opposite corner of the chip. Again, an image of the alignment mark is displayed. At this stage, the alignment mark is probably misaligned in the x, y, and angular directions. At step 1440, the user adjusts the rotational stage, x-stage, and y-stage, if necessary, to align the mark with the cross hair on the video display. In instances where the rotational stage has been rotated, the first alignment mark will become slightly misaligned. To compensate for this shift, the user repeats the alignment process beginning at step 1450 until both marks are aligned. Of course, image processing techniques may be applied for automated head unit and chip alignment.
FIG. 15 a is an example of an image displayed by the video screen during step 1410. As shown, the first alignment mark (lower left corner of the chip) is not aligned with the cross hair marking. FIG. 15 b exemplifies an image of the first alignment mark after adjustments were made by the user. FIG. 15 c illustrates a typical image displayed by video screen during step 1430. As illustrated, the second alignment mark (upper right corner of the chip) is misaligned in the x, y, and angular directions. FIG. 15 d illustrates an image of the second mark following initial adjustments by the user at step 1440. FIG. 15 e illustrates the orientation of the second alignment mark after the chip has been aligned.
Once the chip is aligned, the vacuum holding the chip on the attachment table is released. Thereafter, the pickup on the head unit removes the chip from the table and aligns it on the cavity of the package. In some embodiments, the chip is mated to the pickup by a vacuum.
Optionally, the user may check to ensure that the chip is correctly aligned on the cavity by examining the chip's alignment marks with the camera. If the chip is out of position, the chip is removed and realigned on the alignment table. If the chip is correctly positioned, the system deposits an adhesive by moving the dispenser along the trough surrounding the cavity. In some embodiments, the vacuum is released before depositing the adhesive in the trough. This step is merely precautionary and implemented to ensure that the vacuum does not cause any adhesive to seep into the cavity. Once the adhesive is deposited, the system reexamines the chip to determine if the adhesive had moved the chip out of position. If the chip is still aligned, the head unit locates the ultraviolet light above the adhesive and cures it for a time sufficient to harden the adhesive, which in one embodiment is about 10 seconds. Otherwise, the chip is realigned.
Upon completion, the chip package will have a variety of uses. For example, the chip package will be useful in sequencing genetic material by hybridization. In sequencing by hybridization, the chip package is mounted on a hybridization station where it is connected to a fluid delivery system. Such system is connected to the package by inserting needles into the ports and puncturing the septums therein. In this manner, various fluids are introduced into the cavity for contacting the probes during the hybridization process.
Usually, hybridization is performed by first exposing the sample with a prehybridization solution. Next, the sample is incubated under binding conditions with a solution containing targets for a suitable binding period. Binding conditions will vary depending on the application and are selected in accordance with the general binding methods known including those referred to in: Maniatis et al., Molecular Cloning: A Laboratory Manual (1989), 2nd Ed., Cold Spring Harbor, N.Y. and Berger and Kimmel, Methods in Enzymology, Volume 152, Guide to Molecular Cloning Techniques (1987), Academic Press, Inc., San Diego, Calif.; Young and Davis (1983) Proc. Natl. Acad. Sci. (U.S.A.) 80: 1194, which are incorporated herein by reference. In some embodiments, the solution may contain about 1 molar of salt and about 1 to 50 nanomolar of targets. Optionally, the fluid delivery system includes an agitator to improve mixing in the cavity, which shortens the incubation period. Finally, the sample is washed with a buffer, which may be 6ÃSSPE buffer, to remove the unbound targets. In some embodiments, the cavity is filled with the buffer after washing the sample.
Thereafter, the package may be aligned on a detection or imaging system, such as those disclosed in U.S. Pat. No. 5,143,854 (Pirrung et al.) or U.S. patent application Ser. No. 08/495,889 (Attorney Docket Number. 11509-117), already incorporated herein by reference for all purposes. Such detection systems may take advantage of the package's asymmetry (i.e., non-flush edge) by employing a holder to match the shape of the package specifically. Thus, the package is assured of being properly oriented and aligned for scanning. The imaging systems are capable of qualitatively analyzing the reaction between the probes and targets. Based on this analysis, sequence information of the targets is extracted.
IV. Details on Alternative Embodiments
a. Chip Package Orientation
FIGS. 16 a-16 b illustrate an alternative embodiment of the package. FIG. 16 a shows a top view and FIG. 16 b shows a bottom view. As shown in FIG. 16 a, a cavity 1620 is located on a top surface 1610 of the package body 1600. The body includes alignment holes 1621 and 1622 that are used, for example, in mating the chip to the package. Optionally, a plurality of ridges 1690 is located at end 1660 of the body. The friction created by ridges 1690 allows the package to be handled easily without slippage.
The body also includes two substantially parallel edges 1630 and 1640. As shown, edge 1640 is narrowed at end 1665 to create an uneven edge 1645. The asymmetrical design of the body facilitates correct orientation when mounted onto detection systems. For example, detection systems may contain a holder, similar to that of an audio cassette tape, in which end 1665 is inserted.
Referring to FIG. 16 b, ports 1670 and 1671 communicate with cavity 1620. A seal is provided for each port to retain fluids in the cavity. Similar to the top surface, the bottom surface may optionally include a plurality of ridges 1690 at end 1660.
FIGS. 17 a-17 b illustrate an alternative embodiment of the package. FIG. 17 a shows a top View and FIG. 17 b shows a bottom view. Referring to FIG. 17 a, a cavity 1720 is located on a top surface 1710 of the package body 1700. The body may be formed in the shape of a disk with two substantially parallel edges 1730 and 1740. Alignment holes 1721 and 1722, which may be different in size or shape, are located on the body. In some embodiments, the package is inserted like an audio cassette tape into detection systems in a direction parallel to edges 1730 and 1740. Edges 1730 and 1740 and alignment holes prevent the package from being inserted incorrectly into the detection systems.
As shown in FIG. 17 b, ports 1730 and 1740 are located on the bottom surface 1715 of the package. Ports 1730 and 1740 communicate with cavity 1720 and each include a seal 1780 for sealing fluids in the cavity.
b. Chip Attachment
FIG. 18 illustrates an alternative embodiment for attaching the chip to the package. As shown, two concentric ledges 1810 and 1820 surround the perimeter of cavity 310. Ledge 1820 supports the chip 120 when mounted above cavity 310. Ledge 1810, which extends beyond chip 120, receives an adhesive 1860 such as ultraviolet cured silicone, cement, or other adhesive for attaching the chip thereto.
FIG. 19 illustrates another embodiment for attaching the chip to the package. According to this embodiment, a ledge 1910 is formed around cavity 310. Preferably, the ledge is sufficiently large to accommodate an adhesive 1920 such as an adhesive film, adhesive layer, tape, or any other adhesive layer. Chip 120 attaches to the package when it contacts the adhesive film.
FIG. 20 a illustrates yet another embodiment for attaching a chip to the package. As shown, a clamp 2010, such as a frame having a plurality of fingers 2015, attaches the chip to the package. FIG. 20 b illustrates a cross sectional view. A ridge 2020 on surface 501 surrounds cavity 310. The ridge includes a ledge 2025 upon which chip 120 rests. Optionally, a gasket or a seal 2070 is located between the ledge and chip to ensure a tight seal around cavity 310. Clamp 2010 is attached to side 2040 of ridge 2020 and surface 501. In some embodiments, clamp 2010 is acoustically welded to the body. Accordingly, clamp 2010 includes energy directors 2050 located at its bottom. Alternatively, screws, clips, adhesives, or other attachment techniques may be used to mate clamp 2010 to the package. When mated, fingers 2015 secure chip 120 to the package.
FIG. 21 illustrates an alternative embodiment for attaching the chip to the package. A ridge 2110, having a notch 2115 at or near the top of ridge 2110, encompasses the cavity 310. Chip 120 is wedged and held into position by notch 2115. Thereafter, a process known as heat staking is used to mount the chip. Heat staking includes applying heat and force at side 2111 of ridge, thus forcing ridge tightly against or around chip 120.
FIG. 22 shows another embodiment of attaching a chip onto a package. As shown, a channel 2250 surrounds cavity 310. A notch 2240 for receiving the chip 120 is formed along or near the top of the cavity 310. In some embodiments, a gasket or seal 2270 is placed at the bottom of the notch to ensure a tight seal when the chip is attached. Once the chip is located at the notch, a V-shaped wedge 2260 is inserted into channel 2250. The wedge forces the body to press against chip's edges and seal 2260, thus mating the chip to the package. This process is known as compression sealing.
Other techniques such as insert molding, wave soldering, surface diffusion, laser welding, shrink wrap, o-ring seal, surface etching, or heat staking from the top may also be employed.
c. Fluid Retention
FIG. 23 shows an alternative embodiment of package that employs check valves to seal the inlets. As shown, depressions 2305 and 2315 communicate with cavity 310 through inlets 350 and 360. Check valves 2310 and 2320, which in some embodiments may be duck-billed check valves, are seated in depressions 2305 and 2315. To introduce a fluid into the cavity, a needle is inserted into the check valve. When the needle is removed, the check valve reseals itself to prevent leakage of the fluid.
FIG. 24 illustrates another package that uses reusable tape for sealing the cavity 310. As shown, a tape 2400 is located above inlets 350 and 360. Preferably, end 2430 of tape is permanently fixed to surface 2480 while end 2410 remains unattached. The mid section 2420 of the tape is comprised of non-permanent adhesive. This design allows inlets to be conveniently sealed or unsealed without completely separating the tape from the package.
FIG. 25 illustrates yet another embodiment of the package that uses plugs to retain fluids within the cavity. As shown, depressions 2520 and 2530 communicate with cavity 310 via inlets 350 and 360. A plug 2510, which in some embodiment may be composed of rubber or other sealing material, is mated to each of the depressions. Plugs 2510 are easily inserted or removed for sealing and unsealing the cavity during the hybridization process.
FIG. 26 a illustrates a package utilizing sliding seals for retaining fluids within the cavity. The seals are positioned in slots 2610 that are located above the inlets. The slots act as runners for guiding the seals to and from the inlets. FIG. 26 b illustrates the seal in greater detail. Seal 2640, which may be composed of rubber, teflon rubber, or other sealing material, is mated to each slot 2610. The seal includes a handle 2650 which extends through the slot. Optionally, the bottom of the seal includes an annular protrusion 2645 to ensure mating with inlet 350. The inlet is sealed or unsealed by positioning the seal appropriately along the slot. Alternatively, spring loaded balls, rotary ball valves, plug valves, or other fluid retention techniques may be employed.
d. Chip Orientation
FIGS. 27 a-27 b illustrate an alternative embodiment of the package. FIG. 27 a illustrates a top view and FIG. 27 b shows a cross sectional view. As shown, package 2700 includes a cavity 2710 on a surface 2705. A chip 2790 having an array of probes 2795 on surface 2791 is mated to the bottom of cavity 2710 with an adhesive 2741. The adhesive, for example, may be silicone, adhesive tape, or other adhesive. Alternatively, clips or other mounting techniques may be employed. Optionally, the bottom of the cavity may include a depression in which a chip is seated.
This configuration provides several advantages such as: 1) permitting the use of any type of substrate (i.e., non-transparent or non-translucent), 2) yielding more chips per wafer since the chip does not require an edge for mounting, and 3) allowing chips of various sizes or multiple chips to be mated to the package.
A cover 2770 is mated to the package for sealing the cavity. Preferably, cover 2770 is composed of a transparent or translucent material such as glass, acrylic, or other material that is penetrable by light. Cover 2270 may be mated to surface 2705 with an adhesive 2772, which in some embodiments may be silicone, adhesive film, or other adhesive. Optionally, a depression may be formed around the cavity such that surface 2271 of the cover is at least flush with surface 2705. Alternatively, the cover may be mated to surface 2705 according to any of the chip attachment techniques described herein.
Inlets 2750 and 2751 are provided and communicate with cavity 2710. Selected fluids are circulated through the cavity via inlets 2750 and 2751. To seal the fluids in the cavity, a septum, plug, or other seal may be employed. In alternative embodiments, any of the fluid retention techniques described herein may be utilized.
e. Parallel Hybridization and Diagnostics
In an alternative embodiment, the body is configured with a plurality of cavities. The cavities, for example, may be in a 96-well micro-titre format. In some embodiments, a chip is mounted individually to each cavity according to the methods described above. Alternatively, the probe arrays may be formed on the wafer in a format matching that of the cavities. Accordingly, separating the wafer is not necessary before attaching the probe arrays to the package. This format provides significant increased throughput by enabling parallel testing of a plurality of samples.
V. Details of an Agitation System
FIG. 28 illustrates an agitation system in detail. As shown, the agitation system 2800 includes two liquid containers 2810 and 2820, which in the some embodiments are about 10 milliliters each. Container 2810 communicates with port 350 via tube 2850 and container 2820 communicates with port 360 via tube 2860. An inlet port 2812 and a vent port 2811 are located at or near the top of container 2810. Container 2820 also includes an inlet port 2822 and a vent 2821 at or near its top. Port 2812 of container 2810 and port 2822 of container 2820 are both connected to a valve assembly 2828 via valves 2840 and 2841. An agitator 2801, which may be a nitrogen gas (N2) or other gas, is connected to valve assembly 2828 by fitting 2851. Valves 2840 and 2841 regulate the flow of N2 into their respective containers. In some embodiments, additional containers (not shown) may be provided, similar to container 2810, for introducing a buffer and/or other fluid into the cavity.
In operation, a fluid is placed into container 2810. The fluid, for example, may contain targets that are to be hybridized with probes on the chip. Container 2810 is sealed by closing port 2811 while container 2820 is vented by opening port 2821. Next, N2 is injected into container 2810, forcing the fluid through tube 2850, cavity 310, and finally into container 2820. The bubbles formed by the N2 agitate the fluid as it circulates through the system. When the amount of fluid in container 2810 nears empty, the system reverses the flow of the fluid by closing valve 2840 and port 2821 and opening valve 2841 and port 2811. This cycle is repeated until the reaction between the probes and targets is completed.
In some applications, foaming may occur when N2 interacts with the fluid. Foaming potentially inhibits the flow of the fluid through the system. To alleviate this problem, a detergent such as CTAB may be added to the fluid. In one embodiment, the amount of CTAB added is about 1 millimolar. Additionally, the CTAB affects the probes and targets positively by increasing the rate at which they bind, thus decreasing the reaction time required.
The system described in FIG. 28 may be operated in an alternative manner. According to this technique, back pressure formed in the second container is used to reverse the flow of the solution. In operation, the fluid is placed in container 2810 and both ports 2811 and 2821 are closed. As N2 is injected into container 2810, the fluid is forced through tube 2850, cavity 310, and finally into container 2820. Because the vent port in container 2820 is closed, the pressure therein begins to build as the volume of fluid and N2 increases. When the amount of fluid in container 2810 nears empty, the flow of N2 into container 2810 is terminated by closing valve 2840. Next, the circulatory system is vented by opening port 2811 of container 2810. As a result, the pressure in container 2820 forces the solution back through the system toward container 2810. In one embodiment, the system is injected with N2 for about 3 seconds and vented for about 3 seconds. This cycle is repeated until hybridization between the probes and targets is completed.
FIG. 29 illustrates an alternative embodiment of the agitation system. System 2900 includes a vortexer 2910 on which the chip package 300 is mounted. A container 2930 for holding the fluid communicates with inlet 350 via tube 2950. A valve 2935 may be provided to control the flow of solution into the cavity. In some embodiments, circulator 2901, which may be a N2 source or other gas source, is connected to container 2930. Alternatively, a pump or other fluid transfer device may be employed. The flow of N2 into container 2930 is regulated by a valve 2936. Circulator 2901 is also connected to inlet tube 2950 via a valve 2902.
A waste container 2920 communicates with port 360 via outlet tube 2955. In one embodiment, a liquid sensor 2940 may be provided for sensing the presence of liquid in outlet tube 2955. Access to the waste container may be controlled by a valve 2921. Optionally, additional containers (not shown), similar to container 2930, may be employed for introducing a buffer or other fluid into the cavity.
The system is initialized by closing all valves and filling container 2930 with, for example, a fluid containing targets. Next, valves 2936, 2935, and 2955 are opened. This allows N2 to enter container 2930 which forces the fluid to flow through tube 2950 and into the cavity. When the cavity is filled, valves 2935, 2936, and 2955 are closed to seal the fluid in the cavity. Next, the vortexer is activated to vibrate the chip package, similar to a paint mixer. In some embodiments, the vortexer may vibrate the package at about 3000 cycles per minutes. The motion mixes the targets in the fluid, shortening the incubation period. In some embodiments, the vortexer rotates the chip package until hybridization is completed. Upon completion, valve 2902 and 2955 are opened to allow N2 into the cavity. The N2 empties the fluid into waste container 2920. Subsequently, the cavity may be filled with a buffer or other fluid.
FIG. 30 illustrates an alternative embodiment in which the agitation system is partially integrated into the chip package. As shown, chip package 300 includes a cavity 310 on which the chip is mounted. Cavity 310 is provided with inlets 360 and 350. The package also includes chambers 3010 and 3020. A port 3021 is provided in chamber 3010 and is connected to inlet 360 by a channel 3025.
Chamber 3010 is equipped with ports 3011 and 3012. Port 3012 communicates with inlet 350 through a channel 3015. Channel 3015 is provided with a waste port 3016 that communicates with a fluid disposal system 3500 via a tube 3501. A valve 3502 regulates the flow of fluids into the disposal system. In some embodiments, the disposal system includes a waste container 3510 and fluid recovery container 3520 which are connected to tube 3501. A valve 3530 is provided to direct the flow of fluids into either the waste container or recovery container.
Port 3011 is coupled to a fluid delivery system 3600 through a tube 3601. Fluids flowing into chamber 3010 from the fluid delivery system are regulated by a valve 3602. The fluid delivery system includes fluid containers 3610 and 3620 that are interconnected with a tube 3690. Container 3610, which may hold a fluid containing targets, includes ports 3616 and 3615. Port 3616 is connected to tube 3690. A valve 3612 controls the flow of the fluid out of container 3610. A circulator 3605, which may be a N2 source, is connected to port 3615 of container 3610. Alternatively, any type of gas, pump or other fluid transfer device may be employed. The flow of N2 into container 3610 is controlled by a valve 3618. A valve 3619 may also be provided to vent container 3610.
Container 3620, which may hold a buffer, is provided with ports 3625 and 3626. Circulator 3605 is connected to port 3625. A valve 3621 is provided to control the flow of N2 into container 3620. Port 3626 is connected to tube 3690 via a valve 3622. Valve 3622 regulates the flow of the buffer out of container 3620. Optionally, additional containers (not shown), similar to container 3620, may be configured for introducing other fluids into the cavity. A valve 3690 connects circulator 3605 to tube 3690 for controlling the flow of N2 directly into the package. A valve 3652 is provided for venting the fluid delivery system.
In the initial operating state, all valves are shut. To start the hybridization process, a fluid containing targets is introduced into chamber 301 by opening valves 3602, 3612 and 3618. This injects N2 into container 3610 which forces the fluid to flow through 3601 and into chamber 3010. When chamber 3010 is filled, valves 3612 and 3618 are closed. Next, valve 3642 is opened, allowing N2 to flow directly into chamber 3010. The N2 agitates and circulates the fluid into cavity 310 and out to chamber 3020. As the volume of fluid and N2 in chamber 3020 increase, likewise does the pressure therein. When chamber 3020 approaches its capacity, valve 3642 is closed to stop the fluid flow. Thereafter, the system is vented by opening valve 3652. Venting the system allows the back pressure in chamber 3020 to reverse the flow of fluids back into chamber 3010. When chamber 3010 is filled, valve 3652 is closed and valve 3642 is opened to reverse the fluid flow. This cycle is repeated until hybridization is completed.
When hybridization is completed, the system may be drained. This procedure depends on which chamber the fluid is located in. If the fluid is located in chamber 3020, then valve 3502 is opened, while valve 3530 is positioned to direct the fluid into the appropriate container (recovery or waste). The pressure in chamber 3020 forces the fluid through port 3016, tube 3501, and into the disposal system. If the fluid is in chamber 3010, then valve 3502 and 3642 are opened. As a result, N2 forces the fluid in chamber 3010 through port 3501 and into the disposal system.
Once the system is emptied, all valves are closed. A buffer or other fluid may be introduced into the cavity. For example, the cavity may be filled with a buffer by opening valves 3601, 3621, and 3622. This injects N2 into container 3620 which forces the buffer therein to flow through the system until it fills cavity 310. In the alternative, ultrasonic radiation, heat, magnetic beads, or other agitation techniques may be employed.
The present inventions provide commercially feasible devices for packaging a probe chip. It is to be understood that the above description is intended to be illustrative and not restrictive. Many embodiments will be apparent to those skilled in the art upon reviewing the above description. Merely as an example, the package may be molded or machined from a single piece of material instead of two. Also, other asymmetrical designs may be employed to orient the package onto the detection systems.
The scope of the invention should, therefore, be determined not with reference to the above description, but instead should be determined with reference to the appended claims along with their full scope of equivalents.
. A method of making probe chips comprising the steps of:
forming a plurality of probe arrays on a wafer;
separating said wafer into a plurality of chips, each of said chips comprising at least one probe array thereon; and
mating at least one of said chips to a package, said package comprising a reaction chamber, said reaction chamber comprising inlets for flowing fluid therein, said at least one probe array in fluid communication with said reaction chamber.
93. An array assay device, said device comprising: (a) a substrate receiving element for receiving a substrate having at least on array thereon, said substrate receiving element comprising a bottom surface; and (b) a compression element for urging said bottom surface in a direction towards a substrate when present in said substrate receiving element so as to hold said bottom surface in a fixed position relative to said substrate.
94. The array assay device according to claim 93 , wherein, when said bottom surface is held in said fixed position relative to a substrate when present in said device, said bottom surface ranges from about 0.1 mm to about 2 mm from said substrate.
95. The array assay device according to claim 93 , wherein said bottom surface further comprises a sealing element for producing a seal around at least one array positioned on a substrate when held in said fixed position.
96. The array assay device according to claim 95 , wherein said seal is substantially vapor and fluid tight.
97. The array assay device according to claim 95 , wherein said sealing element produces an assay volume of from about 10.mu.l to about 1000.mu.l.
98. The array assay device according to claim 95 , wherein said substrate comprises a plurality of arrays and said sealing element produces a plurality of individual seals around each array.
99. The array assay device according to claim 98 , wherein each of said individual seals is substantially vapor and fluid tight.
100. The array assay device according to claim 93 , wherein said sealing element is a gasket
101. The array assay device according to claim 93 , further comprising at least one access port.
102. The array assay device according to claim 101 , wherein said device comprises a plurality of access ports.
103. The array assay device according to claim 101 , wherein said device comprises at least a first fluid introduction port and a second venting port.
104. The array assay device according to claim 101 , wherein said at least one port is resealable.
105. The array assay device according to claim 93 , further comprising a removable array holder.
106. The array assay device according to claim 105 , wherein said array holder is configured to be used with an array scanner.
107. A system for performing array assays, said system comprising: (a) an array assay device according to claim 93; and (b) a substrate having at least one array.
108. A method for performing an array assay, said method comprising: (a) providing an array assay device comprising: (i) a bottom surface, (ii) a substrate receiving element for receiving a substrate having at least on array thereon, and (iii) a compression element for urging said bottom surface in a direction towards a substrate when present in said substrate receiving element so as to hold said bottom surface in a fixed position relative to said substrate; (b) positioning a substrate comprising at least one array in said substrate receiving element; (c) urging said bottom surface in a direction towards said positioned substrate using said compression element, whereby said bottom surface is fixed relative to said substrate present in said receiving element; and (e) contacting a sample to said at least one array.
109. The method according to claim 108 , further comprising producing a seal around said at least one array.
110. The method according to claim 109 , wherein said seal is substantially vapor and fluid tight.
111. The method according to claim 108 , wherein said device comprises at least one port and said sample is introduced through said port.
112. The method according to claim 108 , further comprising mixing said sample with said at least one array.
113. The method according to claim 112 , wherein said mixing is accomplished by an air bubble.
114. The method according to claim 108 , further comprising retaining said substrate in an array holder.
115. A method comprising, following contacting said at least one array to a sample according to claim 108 , reading said at least one array.
116. The method according to claim 115 , where in said at least one array is read while in the array holder of claim 114 .
117. A method comprising forwarding data representing a result of a reading obtained by the method of claim 115 from a first location to a second location.
118. The method according to claim 117 , wherein said second location is remote from said first location.
119. A method comprising receiving data representing a result of a reading obtained by the method of claim 115 .
120. A method for performing an array assay, said method comprising: (a) receiving a pre-packaged substrate having at least one array in the array assay device of claim 93 from a remote site; (b) performing an array assay using said received array assay device; (c) removing said pre-packaged substrate from said array assay device; and (d) reading said at least one array to obtain a result.
121. The method according to claim 120 , wherein said pre-packaged substrate comprises a substrate retained in an array holder in said array assay device.
122. A method for performing an array assay and reading a result of said array assay, said method comprising: (a) performing an array assay using the array assay device of claim 93 comprising a substrate having at least on array retained in an array holder; (b) removing said retained substrate having at least one array from said array assay device; and (c) mounting said retained substrate having at least one array on an array scanner so that said retained substrate having at least one array may be read by said scanner while retained in said array holder.
123. The method according to claim 122 , further comprising reading said mounted at least one array.
124. A kit for performing an assay, said kit comprising: (a) at least one array assay device according to claim 93; and (b) instructions for using said at least one array assay device in an array based assay.
125. The kit according to claim 124 , further comprising at least one array holder.
126. The kit according to claim 124 , further comprising at least one array.
127. The kit according to claim 124 , further comprising reagents for generating a labeled sample.
128. The kit according to claim 124 , wherein said kit further comprises a buffer.
129. The kit according to claim 124 , wherein said kit further comprises a wash medium.
US10/992,043 1994-06-08 2004-11-17 Bioarray chip reaction apparatus and its manufacture Abandoned US20050106615A1 (en) Priority Applications (4) Application Number Priority Date Filing Date Title US10/992,043 US20050106615A1 (en) 1994-06-08 2004-11-17 Bioarray chip reaction apparatus and its manufacture US11/378,954 US20060234267A1 (en) 1994-06-08 2006-03-20 Bioarray chip reaction apparatus and its manufacture US12/265,048 US20090143249A1 (en) 1994-06-08 2008-11-05 Bioarray chip reaction apparatus and its manufacture US12/842,977 US20100298165A1 (en) 1994-06-08 2010-07-23 Bioarray chip reaction apparatus and its manufacture Applications Claiming Priority (8) Application Number Priority Date Filing Date Title US25568294A 1994-06-08 1994-06-08 US08/485,452 US5945334A (en) 1994-06-08 1995-06-07 Apparatus for packaging a chip US09/302,052 US6287850B1 (en) 1995-06-07 1999-04-29 Bioarray chip reaction apparatus and its manufacture US09/907,196 US6399365B2 (en) 1994-06-08 2001-07-17 Bioarray chip reaction apparatus and its manufacture US10/046,623 US6551817B2 (en) 1994-06-08 2002-01-14 Method and apparatus for hybridization US10/229,759 US6733977B2 (en) 1994-06-08 2002-08-28 Hybridization device and method US10/619,224 US20040106130A1 (en) 1994-06-08 2003-07-12 Bioarray chip reaction apparatus and its manufacture US10/992,043 US20050106615A1 (en) 1994-06-08 2004-11-17 Bioarray chip reaction apparatus and its manufacture Related Parent Applications (2) Application Number Title Priority Date Filing Date US10/619,224 Continuation US20040106130A1 (en) 1994-06-08 2003-07-12 Bioarray chip reaction apparatus and its manufacture US10/877,666 Continuation US20050003421A1 (en) 1994-06-08 2004-06-25 Bioarray chip reaction apparatus and its manufacture Related Child Applications (1) Application Number Title Priority Date Filing Date US11/378,954 Continuation US20060234267A1 (en) 1994-06-08 2006-03-20 Bioarray chip reaction apparatus and its manufacture Publications (1) Family ID=27048348 Family Applications (18) Application Number Title Priority Date Filing Date US09/302,052 Expired - Lifetime US6287850B1 (en) 1994-06-08 1999-04-29 Bioarray chip reaction apparatus and its manufacture US09/907,196 Expired - Lifetime US6399365B2 (en) 1994-06-08 2001-07-17 Bioarray chip reaction apparatus and its manufacture US10/046,623 Expired - Fee Related US6551817B2 (en) 1994-06-08 2002-01-14 Method and apparatus for hybridization US10/229,759 Expired - Fee Related US6733977B2 (en) 1994-06-08 2002-08-28 Hybridization device and method US10/619,224 Abandoned US20040106130A1 (en) 1994-06-08 2003-07-12 Bioarray chip reaction apparatus and its manufacture US10/639,696 Expired - Fee Related US7364895B2 (en) 1994-06-08 2003-08-11 Bioarray chip reaction apparatus and its manufacture US10/789,678 Abandoned US20040166525A1 (en) 1994-06-08 2004-02-27 Bioarray chip reaction apparatus and its manufacture US10/795,603 Abandoned US20040171054A1 (en) 1994-06-08 2004-03-08 Bioarray chip reaction apparatus and its manufacture US10/877,666 Abandoned US20050003421A1 (en) 1994-06-08 2004-06-25 Bioarray chip reaction apparatus and its manufacture US10/976,077 Abandoned US20050158819A1 (en) 1994-06-08 2004-10-27 Bioarray chip reaction apparatus and its manufacture US10/980,454 Abandoned US20050084895A1 (en) 1994-06-08 2004-11-02 Bioarray chip reaction apparatus and its manufacture US10/992,043 Abandoned US20050106615A1 (en) 1994-06-08 2004-11-17 Bioarray chip reaction apparatus and its manufacture US10/996,291 Abandoned US20050089953A1 (en) 1994-06-08 2004-11-22 Bioarray chip reaction apparatus and its manufacture US10/996,201 Abandoned US20050106617A1 (en) 1994-06-08 2004-11-22 Bioarray chip reaction apparatus and its manufacture US10/995,882 Abandoned US20050208646A1 (en) 1994-06-08 2004-11-22 Bioarray chip reaction apparatus and its manufacture US11/015,197 Abandoned US20050106618A1 (en) 1994-06-08 2004-12-16 Bioarray chip reaction apparatus and its manufacture US11/259,418 Abandoned US20060040380A1 (en) 1994-06-08 2005-10-26 Bioarray chip reaction apparatus and its manufacture US11/378,954 Abandoned US20060234267A1 (en) 1994-06-08 2006-03-20 Bioarray chip reaction apparatus and its manufacture Family Applications Before (11) Application Number Title Priority Date Filing Date US09/302,052 Expired - Lifetime US6287850B1 (en) 1994-06-08 1999-04-29 Bioarray chip reaction apparatus and its manufacture US09/907,196 Expired - Lifetime US6399365B2 (en) 1994-06-08 2001-07-17 Bioarray chip reaction apparatus and its manufacture US10/046,623 Expired - Fee Related US6551817B2 (en) 1994-06-08 2002-01-14 Method and apparatus for hybridization US10/229,759 Expired - Fee Related US6733977B2 (en) 1994-06-08 2002-08-28 Hybridization device and method US10/619,224 Abandoned US20040106130A1 (en) 1994-06-08 2003-07-12 Bioarray chip reaction apparatus and its manufacture US10/639,696 Expired - Fee Related US7364895B2 (en) 1994-06-08 2003-08-11 Bioarray chip reaction apparatus and its manufacture US10/789,678 Abandoned US20040166525A1 (en) 1994-06-08 2004-02-27 Bioarray chip reaction apparatus and its manufacture US10/795,603 Abandoned US20040171054A1 (en) 1994-06-08 2004-03-08 Bioarray chip reaction apparatus and its manufacture US10/877,666 Abandoned US20050003421A1 (en) 1994-06-08 2004-06-25 Bioarray chip reaction apparatus and its manufacture US10/976,077 Abandoned US20050158819A1 (en) 1994-06-08 2004-10-27 Bioarray chip reaction apparatus and its manufacture US10/980,454 Abandoned US20050084895A1 (en) 1994-06-08 2004-11-02 Bioarray chip reaction apparatus and its manufacture Family Applications After (6) Application Number Title Priority Date Filing Date US10/996,291 Abandoned US20050089953A1 (en) 1994-06-08 2004-11-22 Bioarray chip reaction apparatus and its manufacture US10/996,201 Abandoned US20050106617A1 (en) 1994-06-08 2004-11-22 Bioarray chip reaction apparatus and its manufacture US10/995,882 Abandoned US20050208646A1 (en) 1994-06-08 2004-11-22 Bioarray chip reaction apparatus and its manufacture US11/015,197 Abandoned US20050106618A1 (en) 1994-06-08 2004-12-16 Bioarray chip reaction apparatus and its manufacture US11/259,418 Abandoned US20060040380A1 (en) 1994-06-08 2005-10-26 Bioarray chip reaction apparatus and its manufacture US11/378,954 Abandoned US20060234267A1 (en) 1994-06-08 2006-03-20 Bioarray chip reaction apparatus and its manufacture Country Status (1) Cited By (9) * Cited by examiner, â Cited by third party Publication number Priority date Publication date Assignee Title US20050123907A1 (en) * 1995-06-07 2005-06-09 Affymetrix, Inc. Methods for making a device for concurrently processing multiple biological chip assays US20060234267A1 (en) * 1994-06-08 2006-10-19 Affymetrix, Inc Bioarray chip reaction apparatus and its manufacture US20070267335A1 (en) * 2005-11-02 2007-11-22 Affymetrix, Inc. System and Method for Bubble Removal US8309045B2 (en) 2011-02-11 2012-11-13 General Electric Company System and method for controlling emissions in a combustion system US8501122B2 (en) 2009-12-08 2013-08-06 Affymetrix, Inc. Manufacturing and processing polymer arrays CN103873011A (en) * 2014-03-05 2014-06-18 éå·æ³°åçµåç§ææéå ¬å¸ Automatic folding device of tuning fork chip US8961764B2 (en) 2010-10-15 2015-02-24 Lockheed Martin Corporation Micro fluidic optic design US9067207B2 (en) 2009-06-04 2015-06-30 University Of Virginia Patent Foundation Optical approach for microfluidic DNA electrophoresis detection US9322054B2 (en) 2012-02-22 2016-04-26 Lockheed Martin Corporation Microfluidic cartridge Families Citing this family (353) * Cited by examiner, â Cited by third party Publication number Priority date Publication date Assignee Title US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection US6955915B2 (en) * 1989-06-07 2005-10-18 Affymetrix, Inc. Apparatus comprising polymers EP1231282A3 (en) * 1990-12-06 2005-05-18 Affymetrix, Inc. Methods and compositions for identification of polymers US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials US6741344B1 (en) * 1994-02-10 2004-05-25 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials US6090555A (en) * 1997-12-11 2000-07-18 Affymetrix, Inc. Scanned image alignment systems and methods EP0695941B1 (en) * 1994-06-08 2002-07-31 Affymetrix, Inc. Method and apparatus for packaging a chip US6121048A (en) * 1994-10-18 2000-09-19 Zaffaroni; Alejandro C. Method of conducting a plurality of reactions US5959098A (en) * 1996-04-17 1999-09-28 Affymetrix, Inc. Substrate preparation process US6660233B1 (en) * 1996-01-16 2003-12-09 Beckman Coulter, Inc. Analytical biochemistry system with robotically carried bioarray US6706875B1 (en) * 1996-04-17 2004-03-16 Affyemtrix, Inc. Substrate preparation process CA2318175A1 (en) 1998-02-04 1999-08-12 Invitrogen Corporation Microarrays and uses therefor US6780591B2 (en) 1998-05-01 2004-08-24 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules US7875440B2 (en) 1998-05-01 2011-01-25 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules US6576478B1 (en) * 1998-07-14 2003-06-10 Zyomyx, Inc. Microdevices for high-throughput screening of biomolecules US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening US6186659B1 (en) * 1998-08-21 2001-02-13 Agilent Technologies Inc. Apparatus and method for mixing a film of fluid US7510841B2 (en) * 1998-12-28 2009-03-31 Illumina, Inc. Methods of making and using composite arrays for the detection of a plurality of target analytes US20030215821A1 (en) * 1999-04-20 2003-11-20 Kevin Gunderson Detection of nucleic acid reactions on bead arrays US20060275782A1 (en) 1999-04-20 2006-12-07 Illumina, Inc. Detection of nucleic acid reactions on bead arrays US6893865B1 (en) * 1999-04-28 2005-05-17 Targeted Genetics Corporation Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles US20020042081A1 (en) 2000-10-10 2002-04-11 Eric Henderson Evaluating binding affinities by force stratification and force panning US6573369B2 (en) 1999-05-21 2003-06-03 Bioforce Nanosciences, Inc. Method and apparatus for solid state molecular analysis US20030186311A1 (en) * 1999-05-21 2003-10-02 Bioforce Nanosciences, Inc. Parallel analysis of molecular interactions US20030073250A1 (en) * 1999-05-21 2003-04-17 Eric Henderson Method and apparatus for solid state molecular analysis US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences AU2246601A (en) 1999-08-30 2001-04-10 Illumina, Inc. Methods for improving signal detection from an array US7115423B1 (en) * 1999-10-22 2006-10-03 Agilent Technologies, Inc. Fluidic structures within an array package US6642046B1 (en) 1999-12-09 2003-11-04 Motorola, Inc. Method and apparatus for performing biological reactions on a substrate surface US20050214825A1 (en) * 2000-02-07 2005-09-29 John Stuelpnagel Multiplex sample analysis on universal arrays US7955794B2 (en) * 2000-09-21 2011-06-07 Illumina, Inc. Multiplex nucleic acid reactions US8076063B2 (en) 2000-02-07 2011-12-13 Illumina, Inc. Multiplexed methylation detection methods US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions US6770441B2 (en) * 2000-02-10 2004-08-03 Illumina, Inc. Array compositions and methods of making same US20040146918A1 (en) * 2000-02-18 2004-07-29 Weiner Michael L. Hybrid nucleic acid assembly US6897015B2 (en) * 2000-03-07 2005-05-24 Bioforce Nanosciences, Inc. Device and method of use for detection and characterization of pathogens and biological materials IL152634A0 (en) * 2000-05-04 2003-06-24 Univ Yale High density protein arrays for screening of protein activity US6455007B1 (en) * 2000-06-13 2002-09-24 Symyx Technologies, Inc. Apparatus and method for testing compositions in contact with a porous medium US6511277B1 (en) * 2000-07-10 2003-01-28 Affymetrix, Inc. Cartridge loader and methods ATE402760T1 (en) * 2000-08-15 2008-08-15 Bioforce Nanosciences Inc DEVICE FOR FORMING NANOMOLECULAR NETWORKS US7439056B2 (en) * 2000-11-08 2008-10-21 Surface Logix Inc. Peelable and resealable devices for arraying materials AU2002255515A1 (en) * 2001-02-05 2002-08-19 Board Of Regents, The University Of Texas System The use of mesoscale self-assembly and recognition to effect delivery of sensing reagent for arrayed sensors US7223363B2 (en) * 2001-03-09 2007-05-29 Biomicro Systems, Inc. Method and system for microfluidic interfacing to arrays EP1368497A4 (en) * 2001-03-12 2007-08-15 California Inst Of Techn METHOD AND DEVICE FOR ANALYZING POLYNUCLEOTIDE SEQUENCES BY ASYNCHRONOUS BASE EXTENSION US20040166593A1 (en) * 2001-06-22 2004-08-26 Nolte David D. Adaptive interferometric multi-analyte high-speed biosensor US7297553B2 (en) 2002-05-28 2007-11-20 Nanosphere, Inc. Method for attachment of silylated molecules to glass surfaces US7687437B2 (en) * 2001-07-13 2010-03-30 Nanosphere, Inc. Method for immobilizing molecules onto surfaces AU2002329606A1 (en) * 2001-07-17 2003-03-03 Bioforce Nanosciences, Inc. Combined molecular blinding detection through force microscopy and mass spectrometry WO2003093168A2 (en) * 2001-07-26 2003-11-13 Motorola, Inc. System and methods for mixing within a microfluidic device DE10142019A1 (en) * 2001-08-28 2003-03-20 Philips Corp Intellectual Pty Circuit arrangement for demodulating signals US7042488B2 (en) 2001-09-27 2006-05-09 Fujinon Corporation Electronic endoscope for highlighting blood vessel DE10149684B4 (en) * 2001-10-09 2005-02-17 Clondiag Chip Technologies Gmbh Device for holding a substance library carrier US6767733B1 (en) 2001-10-10 2004-07-27 Pritest, Inc. Portable biosensor apparatus with controlled flow JP2005513457A (en) * 2001-12-19 2005-05-12 ã¢ãã£ã¡ããªãã¯ã¹ ã¤ã³ã³ã¼ãã¬ã¤ããã Array plate and method for constructing array plate US6790620B2 (en) * 2001-12-24 2004-09-14 Agilent Technologies, Inc. Small volume chambers DE10201463B4 (en) 2002-01-16 2005-07-21 Clondiag Chip Technologies Gmbh Reaction vessel for performing array method US20090239233A1 (en) * 2002-01-25 2009-09-24 Applera Corporation Single-tube, ready-to-use assay kits, and methods using same US20030143551A1 (en) * 2002-01-30 2003-07-31 Cattell Herbert F. Reading multiple chemical arrays US20030152934A1 (en) * 2002-02-11 2003-08-14 Industrial Technology Research Institute High performance nucleic acid hybridization device and process DE60332406D1 (en) * 2002-03-15 2010-06-17 Affymetrix Inc System and method for scanning biological materials US7364897B2 (en) * 2002-04-11 2008-04-29 Sequenom, Inc. Methods and devices for performing chemical reactions on a solid support US20040060987A1 (en) * 2002-05-07 2004-04-01 Green Larry R. Digital image analysis method for enhanced and optimized signals in fluorophore detection US20050239193A1 (en) * 2002-05-30 2005-10-27 Bioforce Nanosciences, Inc. Device and method of use for detection and characterization of microorganisms and microparticles US7919308B2 (en) * 2002-06-14 2011-04-05 Agilent Technologies, Inc. Form in place gaskets for assays WO2003106032A1 (en) * 2002-06-14 2003-12-24 Axaron Bioscience Ag Hybridization chamber US7371348B2 (en) * 2002-06-14 2008-05-13 Agilent Technologies Multiple array format US7351379B2 (en) * 2002-06-14 2008-04-01 Agilent Technologies, Inc. Fluid containment structure US20040101444A1 (en) * 2002-07-15 2004-05-27 Xeotron Corporation Apparatus and method for fluid delivery to a hybridization station CN1235028C (en) * 2002-08-16 2006-01-04 æ¸ åå¤§å¦ Ultrasonic method and equipment for cleaning solid matrix after hybridization reaction US20060122372A1 (en) * 2002-08-23 2006-06-08 Reinhold Kerb Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications US7595883B1 (en) 2002-09-16 2009-09-29 The Board Of Trustees Of The Leland Stanford Junior University Biological analysis arrangement and approach therefor US7498176B2 (en) * 2002-09-27 2009-03-03 Roche Nimblegen, Inc. Microarray with hydrophobic barriers US20040110212A1 (en) * 2002-09-30 2004-06-10 Mccormick Mark Microarrays with visual alignment marks US20040259105A1 (en) * 2002-10-03 2004-12-23 Jian-Bing Fan Multiplex nucleic acid analysis using archived or fixed samples US6913931B2 (en) * 2002-10-03 2005-07-05 3M Innovative Properties Company Devices, methods and systems for low volume microarray processing US9740817B1 (en) 2002-10-18 2017-08-22 Dennis Sunga Fernandez Apparatus for biological sensing and alerting of pharmaco-genomic mutation US20040082058A1 (en) * 2002-10-29 2004-04-29 Arthur Schleifer Array hybridization apparatus and method for making uniform sample volumes US20040101861A1 (en) * 2002-11-27 2004-05-27 Little Roger G. Resonant cavity photodiode array for rapid DNA microarray readout US20040115654A1 (en) * 2002-12-16 2004-06-17 Intel Corporation Laser exposure of photosensitive masks for DNA microarray fabrication US7344832B2 (en) * 2003-01-02 2008-03-18 Bioforce Nanosciences, Inc. Method and apparatus for molecular analysis in small sample volumes US20040150217A1 (en) * 2003-01-23 2004-08-05 Heffelfinger David M. Identifying indicia and focusing target US20040157343A1 (en) * 2003-02-06 2004-08-12 Applera Corporation Devices and methods for biological sample preparation US7192703B2 (en) 2003-02-14 2007-03-20 Intel Corporation, Inc. Biomolecule analysis by rolling circle amplification and SERS detection WO2004087865A2 (en) * 2003-03-31 2004-10-14 The Regents Of The University Of California The preparation and application of ligand-biopolymer conjugates US20050064452A1 (en) * 2003-04-25 2005-03-24 Schmid Matthew J. System and method for the detection of analytes US20040214310A1 (en) * 2003-04-25 2004-10-28 Parker Russell A. Apparatus and method for array alignment US7651850B2 (en) * 2003-05-16 2010-01-26 Board Of Regents, The University Of Texas System Image and part recognition technology DE10323197B4 (en) * 2003-05-22 2008-10-02 Clondiag Chip Technologies Gmbh Device for holding and detecting substance libraries US20040241659A1 (en) * 2003-05-30 2004-12-02 Applera Corporation Apparatus and method for hybridization and SPR detection US7214382B2 (en) * 2003-06-05 2007-05-08 Adi Shefer Self-warming or self-heating cosmetic and dermatological compositions and method of use US20040248323A1 (en) * 2003-06-09 2004-12-09 Protometrix, Inc. Methods for conducting assays for enzyme activity on protein microarrays ES2645437T3 (en) 2003-06-12 2017-12-05 Accupath Diagnostic Laboratories, Inc. Method and system for the analysis of high density cell samples US20050064462A1 (en) * 2003-06-17 2005-03-24 Bernd Stein Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms US20050032070A1 (en) * 2003-08-05 2005-02-10 Sebastian Raimundo Polymorphisms in the human gene for CYP2D6 and their use in diagnostic and therapeutic applications US7317415B2 (en) 2003-08-08 2008-01-08 Affymetrix, Inc. System, method, and product for scanning of biological materials employing dual analog integrators US20050037424A1 (en) * 2003-08-13 2005-02-17 Schembri Carol T. Selectable length linear microarrays US8346482B2 (en) * 2003-08-22 2013-01-01 Fernandez Dennis S Integrated biosensor and simulation system for diagnosis and therapy US20050280811A1 (en) * 2003-09-19 2005-12-22 Donald Sandell Grooved high density plate US7557433B2 (en) 2004-10-25 2009-07-07 Mccain Joseph H Microelectronic device with integrated energy source CA2586515A1 (en) * 2003-11-05 2005-05-26 Exact Sciences Corporation Repetitive reversed-field affinity electrophoresis and uses therefor US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides DE20317944U1 (en) * 2003-11-18 2004-03-11 Heiser, Volker, Dr. Sample carrier for molecules US7238521B2 (en) * 2003-11-24 2007-07-03 Biocept, Inc. Microarray hybridization device having bubble-fracturing elements US20050112292A1 (en) * 2003-11-25 2005-05-26 Parker Russell A. Methods for treating at least one member of a microarray structure and methods of using the same EP1716254B1 (en) 2004-02-19 2010-04-07 Helicos Biosciences Corporation Methods for analyzing polynucleotide sequences US20050196761A1 (en) * 2004-03-08 2005-09-08 Thompson Allen C. Array hybridization apparatus and method US20050202445A1 (en) * 2004-03-09 2005-09-15 Thompson Allen C. Thermoplastic array hybridization apparatus and method DE102004011667B4 (en) * 2004-03-10 2006-03-23 Technische Fachhochschule Berlin Device with a semiconductor chip and a microfluidic system and method for the production EP1733234B1 (en) * 2004-04-06 2011-09-14 Mount Sinai School Of Medicine Methods of determining allergen response using microarray immunoassay techinques KR100624420B1 (en) 2004-04-10 2006-09-19 ì¼ì±ì ì주ìíì¬ A microarray in which information about the microarray is stored in the form of spots, a method of manufacturing the same, and a method of using the same. US7476734B2 (en) 2005-12-06 2009-01-13 Helicos Biosciences Corporation Nucleotide analogs JP2008512084A (en) 2004-05-25 2008-04-24 ããªã³ã¹ ãã¤ãªãµã¤ã¨ã³ã·ã¼ãº ã³ã¼ãã¬ã¤ã·ã§ã³ Methods and devices for nucleic acid sequencing US20060003335A1 (en) * 2004-06-30 2006-01-05 Crispino John D Methods for diagnosing acute megakaryoblastic leukemia ES2295737T3 (en) * 2004-07-02 2008-04-16 F. Hoffmann-La Roche Ag DEVICE FOR A RELIABLE ANALYSIS. US7407085B2 (en) * 2004-09-22 2008-08-05 Intel Corporation Apparatus and method for attaching a semiconductor die to a heat spreader US7220622B2 (en) * 2004-09-22 2007-05-22 Intel Corporation Method for attaching a semiconductor die to a substrate and heat spreader AU2005335216A1 (en) * 2004-10-05 2007-02-15 Wyeth Probe arrays for detecting multiple strains of different species US7682782B2 (en) 2004-10-29 2010-03-23 Affymetrix, Inc. System, method, and product for multiple wavelength detection using single source excitation JP2006126204A (en) * 2004-10-29 2006-05-18 Affymetrix Inc Automated method for manufacturing polymer array DE102004056735A1 (en) 2004-11-09 2006-07-20 Clondiag Chip Technologies Gmbh Device for performing and analyzing microarray experiments KR100612879B1 (en) * 2004-12-06 2006-08-14 ì¼ì±ì ì주ìíì¬ Hybridization devices under control of pumps and valves in closed systems US7220549B2 (en) 2004-12-30 2007-05-22 Helicos Biosciences Corporation Stabilizing a nucleic acid for nucleic acid sequencing US8158410B2 (en) 2005-01-18 2012-04-17 Biocept, Inc. Recovery of rare cells using a microchannel apparatus with patterned posts US20090136982A1 (en) * 2005-01-18 2009-05-28 Biocept, Inc. Cell separation using microchannel having patterned posts EP1838442B1 (en) 2005-01-18 2013-09-11 Biocept, Inc. Cell separation using microchannel having patterned posts US20060252087A1 (en) * 2005-01-18 2006-11-09 Biocept, Inc. Recovery of rare cells using a microchannel apparatus with patterned posts US7482120B2 (en) 2005-01-28 2009-01-27 Helicos Biosciences Corporation Methods and compositions for improving fidelity in a nucleic acid synthesis reaction WO2006083917A2 (en) 2005-02-01 2006-08-10 Purdue Research Foundation Laser scanning interferometric surface metrology US20070023643A1 (en) 2005-02-01 2007-02-01 Nolte David D Differentially encoded biological analyzer planar array apparatus and methods US7910356B2 (en) 2005-02-01 2011-03-22 Purdue Research Foundation Multiplexed biological analyzer planar array apparatus and methods US20090068650A1 (en) * 2005-02-11 2009-03-12 Southern Illinois University Metabolic Primers for the Detection of (Per) Chlorate-Reducing Bacteria and Methods of Use Thereof US20090215028A1 (en) * 2005-02-18 2009-08-27 Ellen Paxinos Methods and Compositions for Determining Anti-HIV Drug Susceptibility and Replication Capacity of HIV US8178291B2 (en) 2005-02-18 2012-05-15 Monogram Biosciences, Inc. Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors US20060246576A1 (en) 2005-04-06 2006-11-02 Affymetrix, Inc. Fluidic system and method for processing biological microarrays in personal instrumentation EP1928478A2 (en) * 2005-04-18 2008-06-11 Mia Dr. Levite Method for augmenting the ability of t-cells and other cells for fighting disease and invade diseased organs, for elevating cd3 zeta and tnf-alpha expression in t-cells, and mixing t-cell boosting devices and kit particularly useful in such method US20070072287A1 (en) * 2005-05-23 2007-03-29 Biovitesse, Inc. Biomems cartridges EP2458018A3 (en) 2005-05-27 2012-07-25 Monogram BioSciences, Inc. Methods and compositions for determining resistance of HIV-1 to protease inhibitors WO2006133267A2 (en) 2005-06-06 2006-12-14 Monogram Biosciences, Inc. Methods and compositions for determining altered susceptibility of hiv-1 to anti-hiv drugs WO2006133266A2 (en) * 2005-06-06 2006-12-14 Monogram Biosciences, Inc. Methods for determining resistance or susceptibility to hiv entry inhibitors KR100634545B1 (en) 2005-06-17 2006-10-13 ì¼ì±ì ì주ìíì¬ Microchip assembly US8288151B2 (en) * 2005-06-29 2012-10-16 Canon Kabushiki Kaisha Biochemical reaction cassette US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids WO2007061981A2 (en) * 2005-11-21 2007-05-31 Lumera Corporation Surface plasmon resonance spectrometer with an actuator-driven angle scanning mechanism US9056291B2 (en) 2005-11-30 2015-06-16 Micronics, Inc. Microfluidic reactor system US7763453B2 (en) 2005-11-30 2010-07-27 Micronics, Inc. Microfluidic mixing and analytic apparatus US7463358B2 (en) * 2005-12-06 2008-12-09 Lumera Corporation Highly stable surface plasmon resonance plates, microarrays, and methods US20090176208A1 (en) * 2006-01-04 2009-07-09 Simon Brodie Methods for detecting, identifying and reporting the presence of animal pathological agents US7695956B2 (en) * 2006-01-12 2010-04-13 Biocept, Inc. Device for cell separation and analysis and method of using US9445025B2 (en) 2006-01-27 2016-09-13 Affymetrix, Inc. System, method, and product for imaging probe arrays with small feature sizes US8055098B2 (en) * 2006-01-27 2011-11-08 Affymetrix, Inc. System, method, and product for imaging probe arrays with small feature sizes WO2007098027A2 (en) * 2006-02-17 2007-08-30 Bioprocessors Corp. Microreactor with auxiliary fluid motion control US7397546B2 (en) * 2006-03-08 2008-07-08 Helicos Biosciences Corporation Systems and methods for reducing detected intensity non-uniformity in a laser beam US20080309926A1 (en) * 2006-03-08 2008-12-18 Aaron Weber Systems and methods for reducing detected intensity non uniformity in a laser beam US10522240B2 (en) 2006-05-03 2019-12-31 Population Bio, Inc. Evaluating genetic disorders US7702468B2 (en) 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders WO2007131103A2 (en) * 2006-05-03 2007-11-15 Quadraspec, Inc. Direct printing of patterned hydrophobic wells US20100216657A1 (en) * 2006-05-16 2010-08-26 Arcxis Biotechnologies, Inc. Pcr-free sample preparation and detection systems for high speed biologic analysis and identification EP2021766A2 (en) * 2006-05-17 2009-02-11 Luminex Corporation Chip-based flow cytometer type systems for analyzing fluorescently tagged particles US20080003667A1 (en) * 2006-05-19 2008-01-03 Affymetrix, Inc. Consumable elements for use with fluid processing and detection systems CA2653671A1 (en) * 2006-05-30 2007-12-06 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags EP2366801B1 (en) 2006-06-14 2016-10-19 Verinata Health, Inc Methods for the diagnosis of fetal abnormalities CN101675169B (en) 2006-06-14 2018-01-02 ç»´é纳å¡å¥åº·å ¬å¸ Rare cell analysis is carried out using sample splitting and DNA labels EP2041573B1 (en) * 2006-06-23 2019-09-04 PerkinElmer Health Sciences, Inc. Methods and devices for microfluidic point-of-care immunoassays DE102006030068A1 (en) * 2006-06-28 2008-01-03 M2P-Labs Gmbh Apparatus and method for the supply and removal of fluids in shaken microreactors arrays US7700756B2 (en) * 2006-07-27 2010-04-20 Southern Illinois University Metabolic primers for the detection of perchlorate-reducing bacteria and methods of use thereof WO2008048119A2 (en) * 2006-10-17 2008-04-24 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof US8168135B2 (en) * 2006-11-01 2012-05-01 Shimadzu Corporation Reaction container plate and its reaction processing equipment NZ551157A (en) * 2006-11-08 2008-06-30 Rebecca Lee Roberts Method of identifying individuals at risk of thiopurine drug resistance and intolerance - GMPS US20080230605A1 (en) * 2006-11-30 2008-09-25 Brian Weichel Process and apparatus for maintaining data integrity US20080144899A1 (en) * 2006-11-30 2008-06-19 Manoj Varma Process for extracting periodic features from images by template matching US7522282B2 (en) 2006-11-30 2009-04-21 Purdue Research Foundation Molecular interferometric imaging process and apparatus WO2008066596A2 (en) * 2006-11-30 2008-06-05 Johns Hopkins University Gene expression barcode for normal and diseased tissue classification WO2008075977A2 (en) * 2006-12-19 2008-06-26 Synergenz Bioscience Limited Methods and compositions for the assessment of cardiovascular function and disorders US8930178B2 (en) 2007-01-04 2015-01-06 Children's Hospital Medical Center Processing text with domain-specific spreading activation methods WO2008089495A2 (en) 2007-01-19 2008-07-24 Purdue Research Foundation System with extended range of molecular sensing through integrated multi-modal data acquisition MX2009008461A (en) 2007-02-07 2009-08-17 Decode Genetics Ehf Genetic variants contributing to risk of prostate cancer. US9581595B2 (en) 2007-02-26 2017-02-28 Laboratory Corporation Of America Holdings Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy US20080207960A1 (en) * 2007-02-28 2008-08-28 Eric Lin Methods, compositions, and kits for post-hybridization processing of arrays CA2681722A1 (en) 2007-03-26 2008-10-02 Purdue Research Foundation Method and apparatus for conjugate quadrature interferometric detection of an immunoassay EP2535425A1 (en) * 2007-05-25 2012-12-19 Decode Genetics EHF. Variantes génétiques sur les chr 10q26 utilisées comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein US20090060786A1 (en) * 2007-08-29 2009-03-05 Gibum Kim Microfluidic apparatus for wide area microarrays KR20090029053A (en) * 2007-09-17 2009-03-20 ì¼ì±ì ì주ìíì¬ Method for cutting a substrate along a pattern and chips produced thereby AU2008310530A1 (en) * 2007-10-12 2009-04-16 Decode Genetics Ehf Sequence variants for inferring human pigmentation patterns US8697360B2 (en) 2007-11-30 2014-04-15 Decode Genetics Ehf. Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition US9480982B2 (en) 2007-12-24 2016-11-01 Honeywell International Inc. Reactor for the quantitative analysis of nucleic acids US20090181390A1 (en) * 2008-01-11 2009-07-16 Signosis, Inc. A California Corporation High throughput detection of micrornas and use for disease diagnosis EP2265731A4 (en) 2008-01-25 2012-01-18 Theranostics Lab Methods and compositions for the assessment of drug response WO2009098485A1 (en) * 2008-02-07 2009-08-13 Forensic Sciences Service Ltd Improvements in and relating to analysis US8828657B2 (en) 2008-02-14 2014-09-09 Decode Genetics Ehf. Susceptibility variants for lung cancer AU2009233327B2 (en) 2008-04-01 2014-11-13 Decode Genetics Ehf Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm US20090269800A1 (en) * 2008-04-29 2009-10-29 Todd Covey Device and method for processing cell samples KR101541458B1 (en) * 2008-07-03 2015-08-04 ì¼ì±ì ì주ìíì¬ Fluid mixing method and fluid mixing apparatus CA2729856A1 (en) * 2008-07-04 2010-01-07 Decode Genetics Ehf. Copy number variations predictive of risk of schizophrenia KR20110036608A (en) 2008-07-07 2011-04-07 ëì½ë ì ë¤í±ì¤ ì´ìì´ì¹ìí Genetic variation for breast cancer risk assessment US20100014741A1 (en) * 2008-07-10 2010-01-21 Banville Steven C Methods and apparatus related to gate boundaries within a data space US9183237B2 (en) 2008-07-10 2015-11-10 Nodality, Inc. Methods and apparatus related to gate boundaries within a data space WO2010006303A2 (en) * 2008-07-10 2010-01-14 Nodality, Inc. Methods and apparatus related to management of experiments US20100030719A1 (en) * 2008-07-10 2010-02-04 Covey Todd M Methods and apparatus related to bioinformatics data analysis WO2010018600A1 (en) * 2008-08-12 2010-02-18 Decode Genetics Ehf Genetic variants useful for risk assessment of thyroid cancer US20110212855A1 (en) * 2008-08-15 2011-09-01 Decode Genetics Ehf. Genetic Variants Predictive of Cancer Risk KR101523727B1 (en) * 2008-09-16 2015-05-29 ì¼ì±ì ì주ìíì¬ Bio Chip Package Body, Method Of Forming The Bio Chip Package Body And Bio Chip Package Comprising The Bio Chip Package Body US9034257B2 (en) * 2008-10-27 2015-05-19 Nodality, Inc. High throughput flow cytometry system and method CH699853A1 (en) * 2008-11-13 2010-05-14 Tecan Trading Ag Meter and method for determining provided by a laboratory fluid system parameters. US8039794B2 (en) 2008-12-16 2011-10-18 Quest Diagnostics Investments Incorporated Mass spectrometry assay for thiopurine-S-methyl transferase activity and products generated thereby US8640555B2 (en) * 2009-02-09 2014-02-04 Bioaccel Performance AU2010226726B8 (en) 2009-03-16 2014-08-14 Pangu Biopharma Limited Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities AU2010236913B2 (en) 2009-03-31 2016-03-24 Atyr Pharma, Inc. Compositions and methods comprising aspartyl-tRNA synthetases having non-canonical biological activities AU2010231494B2 (en) 2009-04-03 2016-01-07 Decode Genetics Ehf Genetic markers for risk management of atrial fibrillation and stroke BRPI1014469A2 (en) 2009-04-14 2017-06-27 Biocartis Sa hifu induced cavitation with reduced energy threshold CA2752823C (en) 2009-04-15 2016-08-30 Biocartis Sa Protection of bioanalytical sample chambers KR20120012468A (en) 2009-04-15 2012-02-10 ë¹ì¤ê¹ë¥´ë ìì¤ì Optical detection system for monitoring RTPCR reactions ES2540118T3 (en) 2009-05-06 2015-07-08 Biocartis Nv Device for cutting a sample holder AU2010245598A1 (en) * 2009-05-08 2011-11-17 Decode Genetics Ehf Genetic variants contributing to risk of prostate cancer JP6059014B2 (en) 2009-06-19 2017-01-11 ã¢ãªã¾ã ãã¼ã ãªã ãªã¼ã¸ã§ã³ã 㢠ããã£ã¼ ã³ã¼ãã¬ã¼ã ã¢ã¯ãã£ã³ã° ãªã³ ããã¼ã ãªã ã¢ãªã¾ã ã¹ãã¤ã ã¦ããã¼ã·ãã£ï¼¡ï¼²ï¼©ï¼ºï¼¯ï¼®ï¼¡ ＢＯＡＲＤ ＯＦ ＲＥＧＥＮＴＳï¼ï½ ï½ï½ï½ï½ ï½ï½ï½ï½ï½ï½ï½ï½ï½ ï½ï½ï½ï½ï½ï½ ï½ï½ ï½ï½ ï½ï½ï½ï½ ï½ï½ ＡＲＩＺＯＮＡ ＳＴＡＴＥ ＵＮＩＶＥＲＳＩＴＹ Method for producing devices used in the detection of sample constituents and peptide arrays EP2451977A4 (en) 2009-07-10 2013-01-02 Decode Genetics Ehf Genetic markers associated with risk of diabetes mellitus US10174368B2 (en) 2009-09-10 2019-01-08 Centrillion Technology Holdings Corporation Methods and systems for sequencing long nucleic acids CN102858995B (en) 2009-09-10 2016-10-26 森ç¹çéææ¯æ§è¡å ¬å¸ Targeting sequence measurement EP2496720B1 (en) 2009-11-06 2020-07-08 The Board of Trustees of the Leland Stanford Junior University Non-invasive diagnosis of graft rejection in organ transplant patients JP5601445B2 (en) * 2009-12-14 2014-10-08 ã»ã¤ã³ã¼ã¨ãã½ã³æ ªå¼ä¼ç¤¾ Method of filling test liquid US9539571B2 (en) 2010-01-20 2017-01-10 Honeywell International Inc. Method to increase detection efficiency of real time PCR microarray by quartz material CA2786569C (en) 2010-01-29 2019-04-09 Micronics, Inc. Sample-to-answer microfluidic cartridge KR20110090394A (en) * 2010-02-03 2011-08-10 ì¼ì±ì ì주ìíì¬ Microarray Reaction Apparatus and Method Using The Same KR20110106684A (en) * 2010-03-23 2011-09-29 ì¼ì±ì ì주ìíì¬ Microarray package device and method of manufacturing same US10787701B2 (en) 2010-04-05 2020-09-29 Prognosys Biosciences, Inc. Spatially encoded biological assays CA2797093C (en) 2010-04-26 2019-10-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase US8961960B2 (en) 2010-04-27 2015-02-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases CA2797271C (en) 2010-04-28 2021-05-25 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases AU2011248490B2 (en) 2010-04-29 2016-11-10 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases CN103118693B (en) 2010-04-29 2017-05-03 Atyr å»è¯å ¬å¸ Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases WO2011135459A2 (en) 2010-04-29 2011-11-03 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy ES2668207T3 (en) 2010-05-03 2018-05-17 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic and antibody compositions related to fragments of methionyl-tRNA synthetases proteins AU2011248355B2 (en) 2010-05-03 2017-01-19 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Arginyl-tRNA synthetases CN105820252B (en) 2010-05-03 2020-07-21 Atyr å»è¯å ¬å¸ Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl- α -tRNA synthetases US9062302B2 (en) 2010-05-04 2015-06-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex WO2011143482A2 (en) 2010-05-14 2011-11-17 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases AU2011256366C1 (en) 2010-05-17 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases CA2800375C (en) 2010-05-27 2021-03-09 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases WO2011153277A2 (en) 2010-06-01 2011-12-08 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases CN103118695B (en) 2010-07-12 2016-08-03 Atyrå»è¯å ¬å¸ The discovery for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Glycyl-tRNA synthetase EP2601609B1 (en) 2010-08-02 2017-05-17 Population Bio, Inc. Compositions and methods for discovery of causative mutations in genetic disorders JP5964304B2 (en) 2010-08-25 2016-08-03 ã¨ã¼ã¿ã¤ã¢ã¼ ãã¡ã¼ãï¼ ã¤ã³ã³ã¼ãã¬ã¤ããã Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of tyrosyl-tRNA synthetase WO2012095872A1 (en) 2011-01-13 2012-07-19 Decode Genetics Ehf Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment US20120252682A1 (en) 2011-04-01 2012-10-04 Maples Corporate Services Limited Methods and systems for sequencing nucleic acids EP3401679A1 (en) * 2011-04-20 2018-11-14 Life Technologies Corporation Methods, compositions and systems for sample deposition AU2012265177B2 (en) 2011-06-01 2017-03-02 Medical Prognosis Institute A/S Methods and devices for prognosis of cancer relapse US9404864B2 (en) 2013-03-13 2016-08-02 Denovo Sciences, Inc. System for imaging captured cells US9174216B2 (en) 2013-03-13 2015-11-03 DeNovo Science, Inc. System for capturing and analyzing cells US9103754B2 (en) 2011-08-01 2015-08-11 Denovo Sciences, Inc. Cell capture system and method of use US10466160B2 (en) 2011-08-01 2019-11-05 Celsee Diagnostics, Inc. System and method for retrieving and analyzing particles CN102319593B (en) * 2011-08-16 2013-11-20 å京åæåæ°å çµææ¯è¡ä»½æéå ¬å¸ Cytosis polymer microfluidic chip and preparation method thereof US10221454B2 (en) 2011-10-10 2019-03-05 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders US9599561B2 (en) 2011-10-13 2017-03-21 Affymetrix, Inc. Methods, systems and apparatuses for testing and calibrating fluorescent scanners DK2773779T3 (en) 2011-11-04 2020-11-23 Population Bio Inc METHODS AND COMPOSITIONS FOR DIAGNOSIS, FORECAST AND PREVENTION OF NEUROLOGICAL CONDITIONS WO2013070634A1 (en) 2011-11-07 2013-05-16 Ingenuity Systems, Inc. Methods and systems for identification of causal genomic variants EP3483288B1 (en) 2011-11-30 2022-03-16 Children's Hospital Medical Center Personalized pain management and anesthesia: preemptive risk identification KR102090934B1 (en) 2012-01-09 2020-03-19 í¼í¨ì머 í¬ì¤ ì¬ì´ì¸ìì¦, ìì´ìì¨. Microfluidic reactor system CA2863887C (en) 2012-02-09 2023-01-03 Population Diagnostics, Inc. Methods of screening low frequency gdna variation biomarkers for pervasive developmental disorder (pdd) or pervasive developmental disorder - not otherwise specified (pdd_nos) NZ628126A (en) 2012-02-16 2016-10-28 Atyr Pharma Inc Histidyl-trna synthetases for treating autoimmune and inflammatory diseases WO2014026032A2 (en) 2012-08-08 2014-02-13 Apprise Bio, Inc. Increasing dynamic range for identifying multiple epitopes in cells WO2014043519A1 (en) 2012-09-14 2014-03-20 Population Diagnostics Inc. Methods and compositions for diagnosing, prognosing, and treating neurological conditions US10233495B2 (en) 2012-09-27 2019-03-19 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders EP2917715B1 (en) 2012-11-06 2019-04-03 Biodot, Inc. Controlled printing of a cell sample for karyotyping WO2014074942A1 (en) 2012-11-08 2014-05-15 Illumina, Inc. Risk variants of alzheimer's disease BR112015012239B1 (en) 2012-11-27 2022-07-19 Pontificia Universidad Católica De Chile IN VITRO METHOD OF DIAGNOSIS OF THYROID CANCER KR20150097764A (en) 2012-12-21 2015-08-26 ë§ì´í¬ë¡ëì¤ ì¸ì½í¬ë ì´í°ë. Portable fluorescence detection system and microassay cartridge KR102102123B1 (en) 2012-12-21 2020-04-20 í¼í¨ì머 í¬ì¤ ì¬ì´ì¸ìì¦, ìì´ìì¨. Fluidic circuits and related manufacturing methods WO2014100743A2 (en) 2012-12-21 2014-06-26 Micronics, Inc. Low elasticity films for microfluidic use US9606102B2 (en) 2013-01-26 2017-03-28 Denovo Sciences, Inc. System and method for capturing and analyzing cells US20140256586A1 (en) * 2013-03-09 2014-09-11 The Wistar Institute Of Anatomy And Biology Methods and compositions for diagnosis of colorectal cancer US9707562B2 (en) * 2013-03-13 2017-07-18 Denovo Sciences, Inc. System for capturing and analyzing cells DK2970958T3 (en) 2013-03-15 2018-02-19 Lineage Biosciences Inc METHODS FOR SEQUENCING THE IMMUN REPERTOIR WO2014151117A1 (en) 2013-03-15 2014-09-25 The Board Of Trustees Of The Leland Stanford Junior University Identification and use of circulating nucleic acid tumor markers CA2911308C (en) 2013-05-07 2021-10-19 Micronics, Inc. Device for preparation and analysis of nucleic acids EP2994750B1 (en) 2013-05-07 2020-08-12 PerkinElmer Health Sciences, Inc. Microfluidic devices and methods for performing serum separation and blood cross-matching CA2911303C (en) 2013-05-07 2021-02-16 Micronics, Inc. Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions US10391490B2 (en) 2013-05-31 2019-08-27 Celsee Diagnostics, Inc. System and method for isolating and analyzing cells US9856535B2 (en) 2013-05-31 2018-01-02 Denovo Sciences, Inc. System for isolating cells US10392667B2 (en) 2013-06-07 2019-08-27 Medical Prognosis Institute A/S Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients WO2015021080A2 (en) 2013-08-05 2015-02-12 Twist Bioscience Corporation De novo synthesized gene libraries GB2535382A (en) 2013-11-07 2016-08-17 Univ Leland Stanford Junior Cell-free nucleic acids for the analysis of the human microbiome and components thereof CN106132555B (en) 2013-11-11 2019-07-26 çå½ç§æè¡ä»½æéå ¬å¸ Rotor stack and its application method EP2891722B1 (en) 2013-11-12 2018-10-10 Population Bio, Inc. Methods and compositions for diagnosing, prognosing, and treating endometriosis WO2015085066A1 (en) 2013-12-06 2015-06-11 BacterioScan Inc. Optical measurement cuvette having sample chambers CN106460042A (en) 2014-02-24 2017-02-22 å¿ç«¥å»é¢å»å¦ä¸å¿ Methods and compositions for personalized pain management DK3169815T3 (en) 2014-07-15 2021-02-15 Ontario Institute For Cancer Res METHODS AND DEVICES FOR PREDICTING THE EFFICIENCY OF ANTHRACYCLINE TREATMENT WO2016023026A1 (en) 2014-08-08 2016-02-11 Children's Hospital Medical Center Diagnostic method for distinguishing forms of esophageal eosinophilia WO2016036403A1 (en) 2014-09-05 2016-03-10 Population Diagnostics Inc. Methods and compositions for inhibiting and treating neurological conditions CA2975852A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly WO2016126987A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Compositions and methods for synthetic gene assembly AU2016220404B2 (en) 2015-02-17 2021-05-27 Mgi Tech Co., Ltd. DNA sequencing using controlled strand displacement WO2016172377A1 (en) 2015-04-21 2016-10-27 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis US10758886B2 (en) 2015-09-14 2020-09-01 Arizona Board Of Regents On Behalf Of Arizona State University Conditioned surfaces for in situ molecular array synthesis EA201890763A1 (en) 2015-09-18 2018-08-31 ТвиÑÑ ÐайоÑÐ°Ð¹ÐµÐ½Ñ ÐоÑпоÑейÑн LIBRARIES OF OPTIONAL OLEG-NUCLEIC ACIDS AND THEIR SYNTHESIS KR102794025B1 (en) 2015-09-22 2025-04-09 í¸ìì¤í¸ ë°ì´ì¤ì¬ì´ì¸ì¤ ì½í¬ë ì´ì Flexible substrates for nucleic acid synthesis US11065616B2 (en) * 2015-11-23 2021-07-20 King Abdullah University Of Science And Technology Methods of making microfluidic devices CN115920796A (en) 2015-12-01 2023-04-07 ç¹é¦æ¯ç¹çç©ç§å¦å ¬å¸ Functionalized surfaces and preparation thereof CN105413613A (en) * 2015-12-22 2016-03-23 å¤©æ´¥æ ¼ä¿¡æºè½ç§ææéå ¬å¸ Heat exchange device US10821094B2 (en) 2016-01-13 2020-11-03 Children's Hospital Medical Center Compositions and methods for treating allergic inflammatory conditions US20170216845A1 (en) * 2016-01-28 2017-08-03 Becton, Dickinson And Company Enhanced composite liquid cell (clc) devices, and methods for using the same US9659838B1 (en) * 2016-03-28 2017-05-23 Lockheed Martin Corporation Integration of chip level micro-fluidic cooling in chip packages for heat flux removal KR20190019190A (en) 2016-06-20 2019-02-26 í¬ì¤í ì¸í¬. Diagnosis and treatment of autoimmune diseases CA3028960A1 (en) 2016-06-20 2017-12-28 Healthtell Inc. Methods for differential diagnosis of autoimmune diseases CA3034769A1 (en) 2016-08-22 2018-03-01 Twist Bioscience Corporation De novo synthesized nucleic acid libraries WO2018057526A2 (en) 2016-09-21 2018-03-29 Twist Bioscience Corporation Nucleic acid based data storage EP3538893A4 (en) 2016-11-11 2020-09-23 Healthtell Inc. Methods for identifying candidate biomarkers WO2018112426A1 (en) 2016-12-16 2018-06-21 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof CN106807468A (en) * 2017-01-18 2017-06-09 广ä¸é¡ºå¾·å·¥ä¸è®¾è®¡ç 究é¢(广ä¸é¡ºå¾·åæ°è®¾è®¡ç 究é¢) Micro-fluidic chip clamp and droplet preparation system EP3571309A4 (en) 2017-01-20 2020-11-25 Children's Hospital Medical Center PROCEDURES AND COMPOSITIONS RELATED TO OPRM1 DNA METHYLATION FOR PERSONALIZED PAIN MANAGEMENT US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test CN118116478A (en) 2017-02-22 2024-05-31 ç¹é¦æ¯ç¹çç©ç§å¦å ¬å¸ Nucleic acid-based data storage US10894959B2 (en) 2017-03-15 2021-01-19 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof US11376598B2 (en) * 2017-05-12 2022-07-05 Universal Bio Research Co., Ltd. Cartridge for nucleic acid detection WO2018231864A1 (en) 2017-06-12 2018-12-20 Twist Bioscience Corporation Methods for seamless nucleic acid assembly SG11201912057RA (en) 2017-06-12 2020-01-30 Twist Bioscience Corp Methods for seamless nucleic acid assembly CA3074461A1 (en) 2017-08-29 2019-03-07 Celsee Diagnostics, Inc. System and method for isolating and analyzing cells SG11202002194UA (en) 2017-09-11 2020-04-29 Twist Bioscience Corp Gpcr binding proteins and synthesis thereof WO2019055618A1 (en) 2017-09-15 2019-03-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods of classifying response to immunotherapy for cancer WO2019060716A1 (en) 2017-09-25 2019-03-28 Freenome Holdings, Inc. Methods and systems for sample extraction JP7066840B2 (en) 2017-10-20 2022-05-13 ãã¤ã¹ã ãã¤ãªãµã¤ã¨ã³ã¹ ã³ã¼ãã¬ã¼ã·ã§ã³ Heated nanowells for polynucleotide synthesis KR20250069684A (en) 2018-01-04 2025-05-19 í¸ìì¤í¸ ë°ì´ì¤ì¬ì´ì¸ì¤ ì½í¬ë ì´ì Dna-based digital information storage US11859250B1 (en) 2018-02-23 2024-01-02 Children's Hospital Medical Center Methods for treating eosinophilic esophagitis JP2019158794A (en) * 2018-03-16 2019-09-19 ã·ã¹ã¡ãã¯ã¹æ ªå¼ä¼ç¤¾ Specimen treatment method, specimen treatment chip, and specimen treatment apparatus CA3100739A1 (en) 2018-05-18 2019-11-21 Twist Bioscience Corporation Polynucleotides, reagents, and methods for nucleic acid hybridization CA3108807A1 (en) 2018-08-08 2020-02-13 Pml Screening, Llc Methods for assessing the risk of developing progressive multifocal leukoencephalopathy caused by john cunningham virus by genetic testing EP3894588A1 (en) 2018-12-10 2021-10-20 10X Genomics, Inc. Resolving spatial arrays using deconvolution US12297501B2 (en) 2019-02-25 2025-05-13 Children's Hospital Medical Center Methods for diagnosing and treating eosinophilic gastritis CN113785057A (en) 2019-02-26 2021-12-10 ç¹é¦æ¯ç¹çç©ç§å¦å ¬å¸ Variant nucleic acid libraries for antibody optimization JP2022521551A (en) 2019-02-26 2022-04-08 ãã¤ã¹ã ãã¤ãªãµã¤ã¨ã³ã¹ ã³ã¼ãã¬ã¼ã·ã§ã³ GLP1 receptor mutant nucleic acid library WO2020180813A1 (en) 2019-03-06 2020-09-10 Qiagen Sciences, Llc Compositions and methods for adaptor design and nucleic acid library construction for rolony-based sequencing WO2020201267A1 (en) 2019-04-01 2020-10-08 Københavns Universitet Identification of pan-gamma secretase inhibitor (pan-gsi) theranostic response signatures for cancers US10633693B1 (en) 2019-04-16 2020-04-28 Celsee Diagnostics, Inc. System and method for leakage control in a particle capture system JP6886668B2 (en) * 2019-04-23 2021-06-16 ä½åã´ã å·¥æ¥æ ªå¼ä¼ç¤¾ Medical testing equipment and cell testing method WO2020227309A1 (en) 2019-05-07 2020-11-12 Bio-Rad Laboratories, Inc. System and method for automated single cell processing US11273439B2 (en) 2019-05-07 2022-03-15 Bio-Rad Laboratories, Inc. System and method for target material retrieval from microwells CN118291246A (en) 2019-06-14 2024-07-05 伯ä¹å®éªå®¤æéå ¬å¸ Systems and methods for automated single cell processing and analysis WO2020257612A1 (en) 2019-06-21 2020-12-24 Twist Bioscience Corporation Barcode-based nucleic acid sequence assembly AU2020356471A1 (en) 2019-09-23 2022-04-21 Twist Bioscience Corporation Variant nucleic acid libraries for CRTH2 AU2020355027A1 (en) 2019-09-23 2022-04-21 Twist Bioscience Corporation Antibodies that bind CD3 Epsilon EP4038222A4 (en) 2019-10-02 2023-10-18 Arizona Board of Regents on behalf of Arizona State University Methods and compositions for identifying neoantigens for use in treating and preventing cancer US12157124B2 (en) 2019-11-06 2024-12-03 10X Genomics, Inc. Imaging system hardware US11768175B1 (en) 2020-03-04 2023-09-26 10X Genomics, Inc. Electrophoretic methods for spatial analysis US11504719B2 (en) 2020-03-12 2022-11-22 Bio-Rad Laboratories, Inc. System and method for receiving and delivering a fluid for sample processing AU2021288090A1 (en) * 2020-06-10 2023-01-19 10X Genomics, Inc. Fluid delivery methods US20230351619A1 (en) 2020-09-18 2023-11-02 10X Genomics, Inc. Sample handling apparatus and image registration methods WO2022140028A1 (en) 2020-12-21 2022-06-30 10X Genomics, Inc. Methods, compositions, and systems for capturing probes and/or barcodes WO2022178267A2 (en) 2021-02-19 2022-08-25 10X Genomics, Inc. Modular assay support devices EP4063709A1 (en) * 2021-03-22 2022-09-28 Roche Diagnostics GmbH Laboratory system and corresponding method of operation USD1064308S1 (en) 2021-09-17 2025-02-25 10X Genomics, Inc. Sample handling device KR102448538B1 (en) * 2021-10-15 2022-09-30 주ìíì¬ ì§ìì¤í Fishal reaction vessel equipped with dispensing guide and fishal kit including same WO2023122033A1 (en) 2021-12-20 2023-06-29 10X Genomics, Inc. Self-test for pathology/histology slide imaging device WO2024123733A1 (en) 2022-12-05 2024-06-13 Twist Bioscience Corporation Enzymes for library preparation WO2024220475A1 (en) 2023-04-21 2024-10-24 Twist Bioscience Corporation Polymerase variants Citations (93) * Cited by examiner, â Cited by third party Publication number Priority date Publication date Assignee Title US3281860A (en) * 1964-11-09 1966-10-25 Dick Co Ab Ink jet nozzle US3690836A (en) * 1966-03-01 1972-09-12 Promoveo Device for use in the study of chemical and biological reactions and method of making same US3710933A (en) * 1971-12-23 1973-01-16 Atomic Energy Commission Multisensor particle sorter US3802966A (en) * 1969-08-22 1974-04-09 Ethyl Corp Apparatus for delivering a fluid suspension to a forming unit clear reactor power plant US4016855A (en) * 1974-09-04 1977-04-12 Hitachi, Ltd. Grinding method US4121222A (en) * 1977-09-06 1978-10-17 A. B. Dick Company Drop counter ink replenishing system US4125828A (en) * 1972-08-04 1978-11-14 Med-El Inc. Method and apparatus for automated classification and analysis of cells US4159875A (en) * 1976-10-21 1979-07-03 Abbott Laboratories Specimen holder US4204929A (en) * 1978-04-18 1980-05-27 University Patents, Inc. Isoelectric focusing method US4373071A (en) * 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides US4458066A (en) * 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides US4500707A (en) * 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides US4728502A (en) * 1984-05-02 1988-03-01 Hamill Brendan J Apparatus for the chemical synthesis of oligonucleotides US4731325A (en) * 1984-02-17 1988-03-15 Orion-Yhtyma Arrays of alternating nucleic acid fragments for hybridization arrays US4753775A (en) * 1985-04-12 1988-06-28 E. I. Du Pont De Nemours And Company Rapid assay processor US4780504A (en) * 1985-06-20 1988-10-25 Roussel Uclaf Supports useful in solid phase synthesis of oligonucleotides US4812512A (en) * 1985-06-27 1989-03-14 Roussel Uclaf Supports and their use US4815274A (en) * 1984-11-19 1989-03-28 Vincent Patents Limited Exhaust systems for multi-cylinder internal combustion engines US4845552A (en) * 1987-08-20 1989-07-04 Bruno Jaggi Quantitative light microscope using a solid state detector in the primary image plane US4853335A (en) * 1987-09-28 1989-08-01 Olsen Duane A Colloidal gold particle concentration immunoassay US4877745A (en) * 1986-11-17 1989-10-31 Abbott Laboratories Apparatus and process for reagent fluid dispensing and printing US4878971A (en) * 1987-01-28 1989-11-07 Fuji Photo Film Co., Ltd. Method of continuously assembling chemical analysis slides US4912035A (en) * 1987-06-11 1990-03-27 Eastman Kodak Company Method for minimizing interference by reductants when detecting cells in biological fluids US4963498A (en) * 1985-08-05 1990-10-16 Biotrack Capillary flow device US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme US4992383A (en) * 1988-08-05 1991-02-12 Porton Instruments, Inc. Method for protein and peptide sequencing using derivatized glass supports US5021550A (en) * 1986-10-07 1991-06-04 Thomas Jefferson University Method for preventing deletion sequences in solid phase synthesis US5047524A (en) * 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification US5091652A (en) * 1990-01-12 1992-02-25 The Regents Of The University Of California Laser excited confocal microscope fluorescence scanner and method US5100626A (en) * 1990-05-24 1992-03-31 Levin Andrew E Binding assay device with removable cassette and manifold US5141813A (en) * 1989-08-28 1992-08-25 Clontech Laboratories, Inc. Multifunctional controlled pore glass reagent for solid phase oligonucleotide synthesis US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof US5153319A (en) * 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides US5188963A (en) * 1989-11-17 1993-02-23 Gene Tec Corporation Device for processing biological specimens for analysis of nucleic acids US5200051A (en) * 1988-11-14 1993-04-06 I-Stat Corporation Wholly microfabricated biosensors and process for the manufacture and use thereof US5204253A (en) * 1990-05-29 1993-04-20 E. I. Du Pont De Nemours And Company Method and apparatus for introducing biological substances into living cells US5256549A (en) * 1986-03-28 1993-10-26 Chiron Corporation Purification of synthetic oligomers US5281540A (en) * 1988-08-02 1994-01-25 Abbott Laboratories Test array for performing assays US5281516A (en) * 1988-08-02 1994-01-25 Gene Tec Corporation Temperature control apparatus and method US5287272A (en) * 1988-04-08 1994-02-15 Neuromedical Systems, Inc. Automated cytological specimen classification system and method US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support US5300779A (en) * 1985-08-05 1994-04-05 Biotrack, Inc. Capillary flow device US5300799A (en) * 1991-11-08 1994-04-05 Rohm Co., Ltd. Nonvolatile semiconductor storage device with ferroelectric capacitors US5304487A (en) * 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices US5310469A (en) * 1991-12-31 1994-05-10 Abbott Laboratories Biosensor with a membrane containing biologically active material US5314829A (en) * 1992-12-18 1994-05-24 California Institute Of Technology Method for imaging informational biological molecules on a semiconductor substrate US5320808A (en) * 1988-08-02 1994-06-14 Abbott Laboratories Reaction cartridge and carousel for biological sample analyzer US5322799A (en) * 1988-02-03 1994-06-21 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Observation cell and mixing chamber US5346672A (en) * 1989-11-17 1994-09-13 Gene Tec Corporation Devices for containing biological specimens for thermal processing US5358691A (en) * 1992-03-27 1994-10-25 Abbott Laboratories Automated continuous and random access analytical system US5382511A (en) * 1988-08-02 1995-01-17 Gene Tec Corporation Method for studying nucleic acids within immobilized specimens US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths US5486335A (en) * 1992-05-01 1996-01-23 Trustees Of The University Of Pennsylvania Analysis based on flow restriction US5486452A (en) * 1981-04-29 1996-01-23 Ciba-Geigy Corporation Devices and kits for immunological analysis US5494124A (en) * 1993-10-08 1996-02-27 Vortexx Group, Inc. Negative pressure vortex nozzle US5498392A (en) * 1992-05-01 1996-03-12 Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification device and method US5545531A (en) * 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays US5631734A (en) * 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials US5637469A (en) * 1992-05-01 1997-06-10 Trustees Of The University Of Pennsylvania Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems US5639612A (en) * 1992-07-28 1997-06-17 Hitachi Chemical Company, Ltd. Method for detecting polynucleotides with immobilized polynucleotide probes identified based on Tm US5639423A (en) * 1992-08-31 1997-06-17 The Regents Of The University Of Calfornia Microfabricated reactor US5639428A (en) * 1994-07-19 1997-06-17 Becton Dickinson And Company Method and apparatus for fully automated nucleic acid amplification, nucleic acid assay and immunoassay US5677195A (en) * 1991-11-22 1997-10-14 Affymax Technologies N.V. Combinatorial strategies for polymer synthesis US5707798A (en) * 1993-07-13 1998-01-13 Novo Nordisk A/S Identification of ligands by selective amplification of cells transfected with receptors US5757666A (en) * 1993-04-23 1998-05-26 Boehringer Mannheim Gmbh System for analyzing compounds contained liquid samples US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples US5910288A (en) * 1997-07-10 1999-06-08 Hewlett-Packard Company Method and apparatus for mixing a thin film of fluid US5919712A (en) * 1993-05-18 1999-07-06 University Of Utah Research Foundation Apparatus and methods for multi-analyte homogeneous fluoro-immunoassays US5945334A (en) * 1994-06-08 1999-08-31 Affymetrix, Inc. Apparatus for packaging a chip US5958760A (en) * 1995-03-28 1999-09-28 Medical Research Council Sample processing device with a chamber forming member US5961923A (en) * 1995-04-25 1999-10-05 Irori Matrices with memories and uses thereof US6096561A (en) * 1992-03-27 2000-08-01 Abbott Laboratories Scheduling operation of an automated analytical system US6121048A (en) * 1994-10-18 2000-09-19 Zaffaroni; Alejandro C. Method of conducting a plurality of reactions US6180351B1 (en) * 1999-07-22 2001-01-30 Agilent Technologies Inc. Chemical array fabrication with identifier US6186659B1 (en) * 1998-08-21 2001-02-13 Agilent Technologies Inc. Apparatus and method for mixing a film of fluid US6215894B1 (en) * 1999-02-26 2001-04-10 General Scanning, Incorporated Automatic imaging and analysis of microarray biochips US6238910B1 (en) * 1998-08-10 2001-05-29 Genomic Solutions, Inc. Thermal and fluid cycling device for nucleic acid hybridization US6258593B1 (en) * 1999-06-30 2001-07-10 Agilent Technologies Inc. Apparatus for conducting chemical or biochemical reactions on a solid surface within an enclosed chamber US6287850B1 (en) * 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture US6355431B1 (en) * 1999-04-20 2002-03-12 Illumina, Inc. Detection of nucleic acid amplification reactions using bead arrays US6396995B1 (en) * 1999-05-20 2002-05-28 Illumina, Inc. Method and apparatus for retaining and presenting at least one microsphere array to solutions and/or to optical imaging systems US6420114B1 (en) * 1999-12-06 2002-07-16 Incyte Genomics, Inc. Microarray hybridization chamber US6429027B1 (en) * 1998-12-28 2002-08-06 Illumina, Inc. Composite arrays utilizing microspheres US20020132241A1 (en) * 2000-02-07 2002-09-19 Jian-Bing Fan Multiplexed detection of analytes US20020150909A1 (en) * 1999-02-09 2002-10-17 Stuelpnagel John R. Automated information processing in randomly ordered arrays US20030032204A1 (en) * 2001-07-19 2003-02-13 Walt David R. Optical array device and methods of use thereof for screening, analysis and manipulation of particles US6544732B1 (en) * 1999-05-20 2003-04-08 Illumina, Inc. Encoding and decoding of array sensors utilizing nanocrystals US20030096239A1 (en) * 2000-08-25 2003-05-22 Kevin Gunderson Probes and decoder oligonucleotides US20030108867A1 (en) * 1999-04-20 2003-06-12 Chee Mark S Nucleic acid sequencing using microsphere arrays US20030132221A1 (en) * 2002-01-16 2003-07-17 Eastern Sources Housewares (Hong Kong) Limited Cooking appliance US6620584B1 (en) * 1999-05-20 2003-09-16 Illumina Combinatorial decoding of random nucleic acid arrays US6682702B2 (en) * 2001-08-24 2004-01-27 Agilent Technologies, Inc. Apparatus and method for simultaneously conducting multiple chemical reactions Family Cites Families (136) * Cited by examiner, â Cited by third party Publication number Priority date Publication date Assignee Title US95073A (en) * 1869-09-21 Improvement in wheat-drills US124029A (en) * 1872-02-27 Improvement in machines for setting button or lacing-hooks US177159A (en) * 1876-05-09 Improvement in leather-punching machines US113724A (en) * 1871-04-18 Improvement in sewing-machines US618659A (en) * 1899-01-31 Centrifugal machine US203492A (en) * 1878-05-07 Improvement in electro-magnets US3745091A (en) * 1970-11-18 1973-07-10 Miles Lab Biological reaction chamber apparatus GB1320426A (en) * 1971-07-06 1973-06-13 Pfizer Multiple solution testing device US4190040A (en) * 1978-07-03 1980-02-26 American Hospital Supply Corporation Resealable puncture housing for surgical implantation US4382512A (en) * 1979-08-06 1983-05-10 The Radiochemical Centre Ltd. Container system for dangerous materials US4608344A (en) * 1981-09-18 1986-08-26 Battelle Memorial Institute Method for the determination of species in solution with an optical wave-guide US4447140A (en) * 1982-09-29 1984-05-08 Campbell Jeptha E Microscope slides US4543088A (en) * 1983-11-07 1985-09-24 American Hospital Supply Corporation Self-sealing subcutaneous injection site GB8509491D0 (en) * 1985-04-12 1985-05-15 Plessey Co Plc Optic waveguide biosensors FR2582221B1 (en) * 1985-05-21 1987-09-25 Applied Precision Ltd IMPLANTABLE CHRONIC INJECTION DEVICE FOR A SUBSTANCE, ESPECIALLY THERAPEUTIC US5348855A (en) 1986-03-05 1994-09-20 Miles Inc. Assay for nucleic acid sequences in an unpurified sample EP0260965B2 (en) 1986-09-18 2002-01-16 Pacific Biotech Inc. Immunodiagnostic device US5714380A (en) * 1986-10-23 1998-02-03 Amoco Corporation Closed vessel for isolating target molecules and for performing amplification US6270961B1 (en) 1987-04-01 2001-08-07 Hyseq, Inc. Methods and apparatus for DNA sequencing and DNA identification US4945552A (en) * 1987-12-04 1990-07-31 Hitachi, Ltd. Imaging system for obtaining X-ray energy subtraction images GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays AU3869289A (en) 1988-07-14 1990-02-05 Baylor College Of Medicine Solid phase assembly and reconstruction of biopolymers US4857053A (en) * 1988-08-29 1989-08-15 Dalton Michael J Matrix septum GB8822228D0 (en) 1988-09-21 1988-10-26 Southern E M Support-bound oligonucleotides GB8829942D0 (en) 1988-12-22 1989-02-15 Isis Innovations Ltd Method KR920700403A (en) 1989-03-07 1992-02-19 í¼ê³ ì¤ ë¯ì¯ë¯¸ Analysis device for liquid samples and analysis method for liquid samples using this analysis device US6955915B2 (en) * 1989-06-07 2005-10-18 Affymetrix, Inc. Apparatus comprising polymers US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection US5196305A (en) 1989-09-12 1993-03-23 Eastman Kodak Company Diagnostic and amplification methods using primers having thymine at 3' end to overcome primer-target mismatch at the 3' end US5192503A (en) * 1990-05-23 1993-03-09 Mcgrath Charles M Probe clip in situ assay apparatus EP0562025B1 (en) 1990-12-06 2001-02-07 Affymetrix, Inc. (a Delaware Corporation) Compounds and their use in a binary synthesis strategy EP1231282A3 (en) 1990-12-06 2005-05-18 Affymetrix, Inc. Methods and compositions for identification of polymers EP0517930B1 (en) * 1991-06-08 1995-05-24 Hewlett-Packard GmbH Method and apparatus for detecting the presence and/or concentration of biomolecules US5474796A (en) 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface US5189963A (en) * 1991-09-30 1993-03-02 Mann Carlton B Combustible atmosphere furnace control system US5846708A (en) 1991-11-19 1998-12-08 Massachusetts Institiute Of Technology Optical and electrical methods and apparatus for molecule detection US5324633A (en) * 1991-11-22 1994-06-28 Affymax Technologies N.V. Method and apparatus for measuring binding affinity FR2684688B1 (en) 1991-12-04 1994-03-18 Bertin Et Cie METHOD FOR SELECTING AT LEAST ONE MUTATION SCREEN, ITS APPLICATION TO A PROCESS FOR QUICK IDENTIFICATION OF POLYMORPHIC ALLELES AND DEVICE FOR ITS IMPLEMENTATION. AU3728093A (en) 1992-02-19 1993-09-13 Public Health Research Institute Of The City Of New York, Inc., The Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids CA2134478C (en) 1992-05-01 2001-12-18 Peter Wilding Microfabricated detection structures JP2673078B2 (en) * 1992-05-27 1997-11-05 æ±èé»æ± æ ªå¼ä¼ç¤¾ Paste type electrode for alkaline secondary battery FI923220A7 (en) 1992-07-14 1994-01-15 Wallac Oy Method and apparatus for processing a sample and a sample collection system US5508200A (en) * 1992-10-19 1996-04-16 Tiffany; Thomas Method and apparatus for conducting multiple chemical assays US5482591A (en) * 1992-10-30 1996-01-09 Specialty Silicone Products, Inc. Laminated seals and method of production WO1994015791A1 (en) * 1993-01-06 1994-07-21 Seiko Epson Corporation Ink jet head CA2119286A1 (en) * 1993-04-15 1994-10-16 Hubert S. Smith, Iii Internally lubricated elastomers for use in biomedical applications US5342581A (en) * 1993-04-19 1994-08-30 Sanadi Ashok R Apparatus for preventing cross-contamination of multi-well test plates US6258325B1 (en) * 1993-04-19 2001-07-10 Ashok Ramesh Sanadi Method and apparatus for preventing cross-contamination of multi-well test plates US5451475A (en) 1993-04-28 1995-09-19 Matsushita Electric Industrial Co., Ltd. Nickel positive electrode for alkaline storage battery and sealed nickel-hydrogen storage battery using nickel positive electrode US5443985A (en) 1993-07-22 1995-08-22 Alberta Research Council Cell culture bioreactor US5427948A (en) * 1993-07-29 1995-06-27 Michigan State University Apparatus for conducting hybridization US5382512A (en) 1993-08-23 1995-01-17 Chiron Corporation Assay device with captured particle reagent CZ90596A3 (en) 1993-09-27 1996-10-16 Arch Dev Corp Composition for effective sequencing of nucleic acid and process for preparing such composition US5374395A (en) 1993-10-14 1994-12-20 Amoco Corporation Diagnostics instrument US5645801A (en) * 1993-10-21 1997-07-08 Abbott Laboratories Device and method for amplifying and detecting target nucleic acids US5421948A (en) * 1993-11-04 1995-06-06 Label-Aire Inc. Box corner labeler having a force reducer US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits FR2714061B1 (en) * 1993-12-16 1996-03-08 Genset Sa Process for the preparation of polynucleotides on solid support and apparatus allowing its implementation. US5578832A (en) * 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device US5661923A (en) * 1994-05-10 1997-09-02 Fellowes; Robert Fishing weight apparatus US5571639A (en) * 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks US5485277A (en) * 1994-07-26 1996-01-16 Physical Optics Corporation Surface plasmon resonance sensor and methods for the utilization thereof US5599668A (en) * 1994-09-22 1997-02-04 Abbott Laboratories Light scattering optical waveguide method for detecting specific binding events US5585069A (en) * 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis US5592289A (en) * 1995-01-09 1997-01-07 Molecular Dynamics Self-aligning mechanism for positioning analyte receptacles US5497392A (en) * 1995-01-26 1996-03-05 The United States Of America As Represented By The United States Department Of Energy Segmented lasing tube for high temperature laser assembly JP3436611B2 (en) * 1995-04-28 2003-08-11 æ¥æ¬ç¹æ®é¶æ¥æ ªå¼ä¼ç¤¾ Method and apparatus for controlling energization of heater for oxygen sensor US6086561A (en) * 1995-05-01 2000-07-11 Science Incorporated Fluid delivery apparatus with reservoir fill assembly US5575769A (en) * 1995-05-30 1996-11-19 Vaillancourt; Vincent L. Cannula for a slit septum and a lock arrangement therefore US6720149B1 (en) * 1995-06-07 2004-04-13 Affymetrix, Inc. Methods for concurrently processing multiple biological chip assays US5607968A (en) * 1995-06-07 1997-03-04 Avon Products, Inc. Topical alkyl-2-O-L-ascorbyl-phosphates US5589136A (en) * 1995-06-20 1996-12-31 Regents Of The University Of California Silicon-based sleeve devices for chemical reactions US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device US5698393A (en) 1995-08-18 1997-12-16 Abbott Laboratories Method for elimination of rheumatoid factor interference in diagnostic assays US5843655A (en) * 1995-09-18 1998-12-01 Affymetrix, Inc. Methods for testing oligonucleotide arrays US5605653A (en) 1995-11-09 1997-02-25 Devos; Jerry Liquid circulation apparatus US5910568A (en) * 1996-01-11 1999-06-08 The Penn State Research Foundation Molecule involved in binding of sperm to egg surfaces and procedures for use of this molecule to enhance or decrease potential fertility US6660233B1 (en) * 1996-01-16 2003-12-09 Beckman Coulter, Inc. Analytical biochemistry system with robotically carried bioarray US5656174A (en) * 1996-02-16 1997-08-12 Solomon Venture Dredging system and method US5851488A (en) 1996-02-29 1998-12-22 Biocircuits Corporation Apparatus for automatic electro-optical chemical assay determination US6114122A (en) 1996-03-26 2000-09-05 Affymetrix, Inc. Fluidics station with a mounting system and method of using US5939251A (en) * 1996-07-12 1999-08-17 Hu; Min Apparatus and method for simplifying the processes in creating a sealed space on slides to conduct molecular biological reactions therein WO1998008092A1 (en) * 1996-08-21 1998-02-26 Smithkline Beecham Corporation Rapid process for arraying and synthesizing bead-based combinatorial libraries US6054100A (en) * 1996-11-18 2000-04-25 Robbins Scientific Corporation Apparatus for multi-well microscale synthesis US5855804A (en) * 1996-12-06 1999-01-05 Micron Technology, Inc. Method and apparatus for stopping mechanical and chemical-mechanical planarization of substrates at desired endpoints US5763870A (en) * 1996-12-13 1998-06-09 Hewlett-Packard Company Method and system for operating a laser device employing an integral power-regulation sensor US5837475A (en) * 1997-01-30 1998-11-17 Hewlett-Packard Co. Apparatus and method for scanning a chemical array US6095561A (en) * 1997-03-07 2000-08-01 Automotive Systems Laboratory, Inc. Multi-chamber inflator US6008892A (en) * 1997-05-23 1999-12-28 Molecular Dynamics, Inc. Optical substrate for enhanced detectability of fluorescence US5948685A (en) * 1998-02-10 1999-09-07 Angros; Lee Analytic plate with containment border and method of use US6713304B2 (en) * 1998-02-10 2004-03-30 Lee H. Angros Method of forming a containment border on an analytic plate US6030582A (en) * 1998-03-06 2000-02-29 Levy; Abner Self-resealing, puncturable container cap US6376619B1 (en) * 1998-04-13 2002-04-23 3M Innovative Properties Company High density, miniaturized arrays and methods of manufacturing same GB9808140D0 (en) * 1998-04-17 1998-06-17 Smiths Industries Plc Self-sealing septa EP2045334A1 (en) 1998-06-24 2009-04-08 Illumina, Inc. Decoding of array sensors with microspheres US6090687A (en) * 1998-07-29 2000-07-18 Agilent Technolgies, Inc. System and method for bonding and sealing microfabricated wafers to form a single structure having a vacuum chamber therein JP2000091077A (en) * 1998-09-11 2000-03-31 Sony Corp Organic electroluminescence element US6165138A (en) * 1998-09-30 2000-12-26 Becton Dickinson And Company Self-sealing closure for a medical speciman collection container SG108217A1 (en) * 1998-12-29 2005-01-28 Toshiba Kk Surface acoustic wave device US6514768B1 (en) * 1999-01-29 2003-02-04 Surmodics, Inc. Replicable probe array US6555361B1 (en) * 1999-03-24 2003-04-29 Corning Incorporated Hybridization chamber for high density nucleic acid arrays US6221653B1 (en) * 1999-04-27 2001-04-24 Agilent Technologies, Inc. Method of performing array-based hybridization assays using thermal inkjet deposition of sample fluids US6323043B1 (en) * 1999-04-30 2001-11-27 Agilent Technologies, Inc. Fabricating biopolymer arrays US6399394B1 (en) * 1999-06-30 2002-06-04 Agilent Technologies, Inc. Testing multiple fluid samples with multiple biopolymer arrays US6395483B1 (en) * 1999-09-02 2002-05-28 3M Innovative Properties Company Arrays with mask layers US6232072B1 (en) * 1999-10-15 2001-05-15 Agilent Technologies, Inc. Biopolymer array inspection ATE527053T1 (en) 1999-12-13 2011-10-15 Illumina Inc SYNTHESIS DEVICE FOR OLIGONUCLEOTIDES USING CENTRIFLY FORCE FR2802121A1 (en) 1999-12-14 2001-06-15 Expansia Sa ORGANIC POLYMERIC SUBSTRATES WITH MONO- OR BI-DENTATE LIGANDS AND THEIR USE IN SUPPORTED CATALYSIS EP1111391B1 (en) * 1999-12-21 2006-07-26 Tecan Trading AG Clamping device for holding and aligning an item such as a microtitration plate, and method for its use US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions US6770441B2 (en) * 2000-02-10 2004-08-03 Illumina, Inc. Array compositions and methods of making same EP1307283A2 (en) 2000-06-28 2003-05-07 Illumina, Inc. Composite arrays utilizing microspheres with a hybridization chamber US6511277B1 (en) * 2000-07-10 2003-01-28 Affymetrix, Inc. Cartridge loader and methods US6545758B1 (en) * 2000-08-17 2003-04-08 Perry Sandstrom Microarray detector and synthesizer US6864097B1 (en) * 2000-09-27 2005-03-08 Agilent Technologies, Inc. Arrays and their reading US6648853B1 (en) 2000-10-31 2003-11-18 Agilent Technologies Inc. Septum US6905816B2 (en) 2000-11-27 2005-06-14 Intelligent Medical Devices, Inc. Clinically intelligent diagnostic devices and methods US6382512B1 (en) * 2001-04-09 2002-05-07 Yu-Chun Chang Signal reading control apparatus for barcode scanner EP1425090A2 (en) 2001-09-07 2004-06-09 Corning Incorporated MICROCOLUMN−PLATFORM BASED ARRAY FOR HIGH−THROUGHPUT ANALYSIS US20030087292A1 (en) * 2001-10-04 2003-05-08 Shiping Chen Methods and systems for promoting interactions between probes and target molecules in fluid in microarrays US20030113724A1 (en) 2001-10-12 2003-06-19 Schembri Carol T. Packaged microarray apparatus and a method of bonding a microarray into a package ES2302845T3 (en) * 2001-10-19 2008-08-01 Zymogenetics, Inc. DIMERIZED GROWTH FACTOR AND MATERIALS AND METHODS TO PRODUCE IT. KR100428514B1 (en) * 2001-11-16 2004-04-29 ê¸í¸ìì íí 주ìíì¬ Polymer consisting of linear and nonlinear structure and process for its manufacture by anionic polymerization JP2005513457A (en) * 2001-12-19 2005-05-12 ã¢ãã£ã¡ããªãã¯ã¹ ã¤ã³ã³ã¼ãã¬ã¤ããã Array plate and method for constructing array plate US7018842B2 (en) * 2002-02-28 2006-03-28 Agilent Technologies, Inc. Reading dry chemical arrays through the substrate DE60332406D1 (en) * 2002-03-15 2010-06-17 Affymetrix Inc System and method for scanning biological materials US7125523B2 (en) 2002-04-29 2006-10-24 Agilent Technologies, Inc. Holders for arrays EP1375678A3 (en) 2002-06-14 2004-03-10 Agilent Technologies, Inc. Methods and compositions for performing array based assays US20030235520A1 (en) 2002-06-21 2003-12-25 Shea Laurence R. Array assay devices and methods of using the same US6835938B2 (en) 2002-07-31 2004-12-28 Agilent Technologies, Inc. Biopolymer array substrate thickness dependent automated focus-distance determination method for biopolymer array scanners US6913931B2 (en) * 2002-10-03 2005-07-05 3M Innovative Properties Company Devices, methods and systems for low volume microarray processing US20040086868A1 (en) * 2002-10-30 2004-05-06 Parker Russell A. Enclosed arrays and their reading US20040096914A1 (en) 2002-11-20 2004-05-20 Ye Fang Substrates with stable surface chemistry for biological membrane arrays and methods for fabricating thereof US20050026299A1 (en) 2003-07-31 2005-02-03 Arindam Bhattacharjee Chemical arrays on a common carrier US7223609B2 (en) * 2003-08-14 2007-05-29 Agilent Technologies, Inc. Arrays for multiplexed surface plasmon resonance detection of biological moleculesFree format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4